Im Shop erwerben
, um zu prüfen, ob Sie einen Vollzugriff auf diese Publikation haben.
Monographie Kein Zugriff

Aufholende Entwicklung in der globalen Ökonomie

Pharmazeutische Innovationssysteme in Indien und Brasilien
Autor:innen:
Verlag:
 19.03.2015

Zusammenfassung

Der Zugang zu technologischem Wissen ist ein Schlüsselfaktor für die ökonomische und soziale Entwicklung aufholender Länder. Gleichzeitig wird dieser durch das im TRIPs-Abkommen verankerte Patentschutzgebot seit Mitte der 1990er Jahre erheblich beschränkt. Am folgenreichsten ist hiervon der pharmazeutische Sektor betroffen, der wegen seiner hohen Technologieintensität und sozialpolitischen Relevanz in aufholenden Ländern seit jeher vom Patentschutz ausgenommen war.

Die Arbeit untersucht die pharmazeutische Technologiegewinnung Indiens und Brasiliens. Es wird gezeigt, dass die beiden Staaten infolge des TRIPs-Abkommens zwei grundlegend verschiedene catching up-Pfade eingeschlagen haben, die auf unterschiedliche Governance-Konfigurationen in den Innovationssystemen beider Länder zurückgeführt werden können.

Publikation durchsuchen

Bibliographische Angaben

Erscheinungsjahr
2015
Erscheinungsdatum
19.03.2015
ISBN-Print
978-3-8487-2132-0
ISBN-Online
978-3-8452-6232-1
Verlag
Nomos, Baden-Baden
Reihe
Vergleichende Analyse politischer Systeme
Band
6
Sprache
Deutsch
Seiten
394
Produkttyp
Monographie

Inhaltsverzeichnis

KapitelSeiten
  1. Titelei/Inhaltsverzeichnis Kein Zugriff 1 - 18
  2. Verzeichnis der Fallbeispiele Kein Zugriff 19 - 20
  3. Einleitung Kein Zugriff 21 - 31
  4. Die Globalisierung pharmazeutisch-technologischer Wissensgewinnung Kein Zugriff 32 - 65
  5. Theoretische Grundlagen: Governance von technologischer Wissensgewinnung Kein Zugriff 66 - 101
  6. Konzept und Methode Kein Zugriff 102 - 127
  7. Indien: Exportorientierte Innovationsförderung durch Markt-Governance Kein Zugriff 128 - 213
  8. Brasilien: Binnenorientierte Versorgungssicherheit durch Hierarchie Kein Zugriff 214 - 303
  9. Vergleich: Pharmazeutische Innovationssysteme in Indien und Brasilien Kein Zugriff 304 - 330
  10. Schlussbetrachtung Kein Zugriff 331 - 353
  11. Quellen- und Literaturverzeichnis Kein Zugriff 354 - 394

Literaturverzeichnis (647)

  1. Abbott, Frederick M. (2005), The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health, American Journal of International Law, 99(2), 317-358. Google Scholar öffnen doi.org/10.2307/1562501
  2. Abramovitz, Moses (1986), Catching Up, Forging Ahead, and Falling Behind, Journal of Economic History, 46(2), 385-406. Google Scholar öffnen doi.org/10.1017/S0022050700046209
  3. Abrol, Dinesh (2004), Post-TRIPS Technological Behaviour of the Pharmaceutical Industry in India, Science, Technology & Society, 9(2), 243-271. Google Scholar öffnen doi.org/10.1177/097172180400900203
  4. Abrol, Dinesh, Pramod Prajapati & Nidhi Singh (2010), Globalization of the Indian pharmaceutical industry: Implications for the direction, distribution and diversity in drug innovation, 8th GLOBELICS International Conference: Making Innovation Work for Society - Linking, Leveraging and Learning, Kuala Lumpur, 01.-03. November. Google Scholar öffnen
  5. Abrol, Dinesh, Pramod Prajapati & Nidhi Singh (2011), Globalization of the Indian Pharmaceutical Industry: Implications for Innovation, International Journal of Institutions and Economies, 3(2), 327-365. Google Scholar öffnen
  6. Abromeit, Heidrun & Michael Stoiber (2006), Demokratien im Vergleich: Einführung in die vergleichende Analyse politischer Systeme, Wiesbaden: VS Verlag für Sozialwissenschaften. Google Scholar öffnen
  7. Adeoti, John Olatunji (2002), Building technological capability in the less developed countries: the role of a national system of innovation, Science and Public Policy, 29(2), 95-104. Google Scholar öffnen doi.org/10.3152/147154302781781083
  8. Adler, Emanuel (1988), State Institutions, Ideology, and Autonomous Technological Development: Computers and Nuclear Energy in Argentina and Brazil, Latin American Research Review, 23(2), 59-90. Google Scholar öffnen
  9. Agência Saúde (2011), Saúde Não Tem Preço: Acesso a medicamentos gratuitos triplica no país, Ministério da Saúde, 13.09.2011. Google Scholar öffnen
  10. Agência Saúde (2013), Ministério da Saúde vai investir R$ 35 bi até 2016 na compra de medicamentos produzidos no País, 23. April, <http://portalsaude.saude.gov.br/portalsaude/impressao/10405/162/ministerio-da-saude-vai-investir-r$-35-bi-ate-2016.html>. Google Scholar öffnen
  11. Aggarwal, Aradhna (2004), Strategic Approach to Strengthening the International Competitiveness in Knowledge Based Industries: The Indian Pharmaceutical Industry, RIS Discussion Paper, 80/2004, New Delhi: Research and Information System for the Non-Aligned and Other Developing Countries. Google Scholar öffnen
  12. Aggarwal, Aradhna (2006), Liberalisation, Technology Policies and Acquisition of Technological Capabilities: A Study of Indian Industry, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen
  13. AGU (2010), Parecer No. 337 /PGF/EA/2010, Brasília: Advocacia-Geral da União Procuradoria-Geral Federal, 04. März. Google Scholar öffnen
  14. Alger, Jackeline et al. (2009), National health research systems in Latin America: a 14-country review, Pan American Journal of Public Health, 26(5), 447-457. Google Scholar öffnen
  15. Altenburg, Tilman (2006), Governance Patterns in Value Chains and their Development Impact, The European Journal of Development Research, 18(4), 498-521. Google Scholar öffnen doi.org/10.1080/09578810601070795
  16. Altenburg, Tilman (2009), Building inclusive innovation systems in developing countries: challenges for IS research, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 33-56. Google Scholar öffnen
  17. Amable, Bruno (2000), Institutional Complementarity and Diversity of Social Systems of Innovation and Production, Review of International Political Economy, 7(4), 645-687. Google Scholar öffnen doi.org/10.1080/096922900750034572
  18. Amann, Edmund (2000), Economic Liberalization and Industrial Performance in Brazil, Oxford: Oxford University Press. Google Scholar öffnen
  19. Amighini, Alessia (2006), Upgrading in International Trade: Methods and Evidence from Selected Sectors in Latin America, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 221-250. Google Scholar öffnen
  20. Amin, Tahir (2007), Voluntary Licensing Practices in the Pharmaceutical Sector: An Acceptable Solution to Improving Access to Affordable Medicines?, Initiative For Medicines, Access & Knowledge, 08.02.07. Google Scholar öffnen
  21. Amsden, Alice H. (1989), Asia’s Next Giant: South Korea and Late Industrialization, Oxford: Oxford University Press. Google Scholar öffnen
  22. Anderson, Warwick H. (2002), Postcolonial technoscience, Social Studies of Science, 32(5-6), 643-658. Google Scholar öffnen doi.org/10.1177/030631202128967361
  23. AnproTec (2008), Portfolio de Parques Tecnológicos no Brasil, Brasília: Associação Nacional de Entidades Promotoras de Empreendimentos Inovadores, Dezember 2008. Google Scholar öffnen
  24. Årdal, Christine (2012), Open Source Drug Discovery in Practice: A Case Study, PLOS Neglected Tropical Diseases, 6(9), 1-11. Google Scholar öffnen doi.org/10.1371/journal.pntd.0001827
  25. Arndt, Sven W. & Henryk Kierzkowski (2001), Introduction, in: Sven W. Arndt & Henryk Kierzkowski (Hrsg.), Fragmentation: new production patterns in the world economy, Oxford: Oxford University Press, 1-16. Google Scholar öffnen doi.org/10.1007/978-3-642-56669-1_2
  26. Arocena, Rodrigo & Judith Sutz (2000), Looking at National Systems of Innovation from the South, Industry and Innovation, 7(1), 55-75. Google Scholar öffnen doi.org/10.1080/713670247
  27. Asheim, Bjorn (2007), Differentiated Knowledge Bases and Varieties of Regional Innovation Systems, Innovation: The European Journal of Social Science Research, 20(3), 223-241. Google Scholar öffnen doi.org/10.1080/13511610701722846
  28. Ashford, Nicholas A. & Ralph P. Hall (2011), Technology, Globalization, and Sustainable Development: Transforming the Industrial State, New Haven: Yale University Press. Google Scholar öffnen
  29. ATX-BA (2012), A ATX-BA Parabeniza a Bahiafarma e a Novartis Pela Iniciativa em Prol Dos Pacientes Transplantados, <http://atxbahia.blogspot.de/2012/12/ Google Scholar öffnen
  30. a-atx-ba-parabeniza-bahiafarma-e.html>. Google Scholar öffnen
  31. Avila, Jorge (2008), Patentes Farmacêuticas no Brasil, 2° Encontro Nacional de Inovação em Fármacos e Medicamentos, Sao Paolo, 12.-13. November. Google Scholar öffnen
  32. Ayyaswamy, Jancy, Neeraj Saxena & Antaryami Parida (2010), Government mediated program on intensifying industry- academia linkages for human resource development; Experiences of an innovative model from TIFAC, Forecasting & Assessment Council (TIFAC) Technology Information. Google Scholar öffnen
  33. Bae, Zong-Tae & Jin-woo Chung (2001), The Impact of External Environment and Technological Learning System on the Relationship Between Technological Alliance and Performance of Korean Small Telecom Firms, Portland International Conference on Management of Engineering and Technology, Portland, 29.07.-02.08. Google Scholar öffnen
  34. Bakhru, Girish & Nam Park (2013), India Pharmaceuticals: Generics are evolving, Mumbai: HSBC Global Research, Juni 2013. Google Scholar öffnen
  35. Baković, Tomislav (2010), Managing innovation systems in transition economies, FEB-Zg working papers, 10-01, Zagreb: Faculty of Economics and Business, The University of Zagreb. Google Scholar öffnen
  36. Balzat, Markus & Horst Hanusch (2004), Recent Trends in the Research on National Innovation Systems, Journal of Evolutionary Economics, 14(2), 197-210. Google Scholar öffnen doi.org/10.1007/s00191-004-0187-y
  37. Barton, John et al. (2002), Integrating Intellectual Property Rights and Development Policy, Report of the Commission on Intellectual Property Rights, London: Commission on Intellectual Property Rights. Google Scholar öffnen
  38. Basant, Rakesh (2006), Intellectual Property Rights Regime and Creation of Innovation based Enterprises in India, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen
  39. Baskaran, Angathevar & Rebecca Boden (2006), Knowledge Capital and Globalisation: Towards a new Conceptual Model, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen
  40. Bassala, George (1967), The Spread of Western Science, Science, 156(3775), 611-622. Google Scholar öffnen doi.org/10.1126/science.156.3775.611
  41. Bastos, Maria Ines (1994), How international sanctions worked: Domestic and foreign political constraints on the Brazilian informatics policy, Journal of Development Studies, 30(2), 380-404. Google Scholar öffnen doi.org/10.1080/00220389408422320
  42. Bastos, Valéria Delgado (2005), Inovação Farmacêutica: Padrão Setorial e Perspectivas para o Caso Brasileiro, BNDES Setorial, 22, 271-296. Google Scholar öffnen
  43. Bazan, Luiza & Lizbeth Navas-Aleman (2004), The underground revolution in the Sinos Valley: a comparison of upgrading in global and national value chains, in: Hubert Schmitz (Hrsg.), Local Enterprises in the Global Economy: issues of governance and upgrading Cheltenham: Edward Elgar, 110-139. Google Scholar öffnen
  44. BBC News (2004), Brazil to break Aids drug patents, 01.12.04. Google Scholar öffnen
  45. Bell, Martin (1984), 'Learning' and the Accumulation of Industrial Technological Capacity in Developing Countries, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London: Macmillan, 187-209. Google Scholar öffnen
  46. Bell, Martin & Keith Pavitt (1993), Technological Accumulation and Industrial Growth: Contrasts Between Developed and Developing Countries, Industrial and Corporate Change, 2(2), 157-210. Google Scholar öffnen doi.org/10.1093/icc/2.1.157
  47. Bessen, James & Michael Meurer (2008), Patent Failure: How Judges, Bureaucrats, and Lawyers Put Innovators at Risk, Princeton: Princeton University Press. Google Scholar öffnen
  48. Bhardwaj, Anshu, Vinod Scaria & Deblina Patra (2011), Open Source Drug Discovery: A Global Collaborative Drug Discovery Model for Tuberculosis, Science and Culture, 77(1-2), 22-26. Google Scholar öffnen doi.org/10.1016/j.tube.2011.06.004
  49. Bhattacharya, Radhika (2008), Are Developing Countries Going Too Far on Trips? A Closer Look at The new Laws in India, American Journal of Law and Medicine, 34(2-3), 395-421. Google Scholar öffnen doi.org/10.1177/009885880803400211
  50. Bhattacharya, Sujit (2006), Harmonization of Patent Rules and Regulations and its Plausible Implications in Developing Countries: A Case Study of India, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen
  51. Bhojwani, Hiro (2005), Developing Innovative Capacity in India to Meet Health Needs, in: Ingrid Hering (Hrsg.), Innovation in Developing Countries to Meet Health Needs: Experiences of China, Brazil, South Africa and India, Oxford: The Centre for Management of IP in Health R&D, 112-153. Google Scholar öffnen
  52. Bianchi Pagola, Carlos F. (2012), O papel das políticas públicas no regime de inovação de biotecnologia para saúde humana: Brasil 2002-2010, Tese de Doutorado, Rio de Janeiro: Instituto de Economia da Universidade Federal do Rio de Janeiro. Google Scholar öffnen
  53. Bidwai, Praful (1995), One Step Forward, Many Steps Back: Dismemberment of India’s National Drug Policy, Development Dialogue, 1995(1), 193-222. Google Scholar öffnen
  54. Bierly, P.E. III & A.K. Chakrabarti (1996), Technological learning, strategic flexibility, and new product development in the pharmaceutical industry, IEEE Transactions on Engineering Management, 43(4), 368-380. Google Scholar öffnen doi.org/10.1109/17.543979
  55. Biocon (2010), Biocon Biopharmaceuticals Private Limited becomes wholly owned subsidiary of Biocon, 05. April, <http://www.biocon.com/biocon_press_release_ Google Scholar öffnen
  56. details.asp?subLink=news&Fileid=384>. Google Scholar öffnen
  57. Biocon (2012), Biocon announces that it has entered into an option agreement with Bristol-Myers Squibb for Biocon’s IN-105, an oral insulin drug candidate, 16. November, <http://www.biocon.com/biocon_inv_press_releases_16112012.asp>. Google Scholar öffnen
  58. Bird, Robert & Daniel R. Cahoy (2008), The Impact of Compulsory Licensing on Foreign Direct Investment: A Collective Bargaining Approach, American Business Law Journal, 45(2), 283-330. Google Scholar öffnen doi.org/10.1111/j.1744-1714.2008.00056.x
  59. Bloch, Harry (Hrsg.) (2003), Growth and development in the global economy, Cheltenham: Edward Elgar. Google Scholar öffnen doi.org/10.4337/9781781009772.00009
  60. Blomstrom, Magnus, Robert E. Lipsey & Mario Zejan (1992), What explains developing country growth?, NBER Working Paper Series, No. 4132, Cambridge: National Bureau of Economic Research. Google Scholar öffnen doi.org/10.3386/w4132
  61. Bloomberg Businessweek (2013), Dr. Reddy's Laboratories, <http://investing. Google Scholar öffnen
  62. businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=DRRD:IN>. Google Scholar öffnen
  63. BMI (2011), Roche Signs Technology-Transfer Deal With Government-Run Drugmaker, Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions, Business Monitor International, April. Google Scholar öffnen
  64. BMI (2012a), DSM To Manufacture Recepta's Antibodies, News and analysis on global M&A and corporate financing strategies, Business Monitor International, Juli. Google Scholar öffnen
  65. BMI (2012b), New Joint Ventures Between Multinationals And Local Drugmakers, News and analysis on global M&A and corporate financing strategies, Business Monitor International, Februar. Google Scholar öffnen
  66. BMI (2012c), Pharmaceutical Trade Surplus To Widen, Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions, Business Monitor International, März 2012. Google Scholar öffnen
  67. Börzel, Tanja A. (2008), Der "Schatten der Hierarchie" — Ein Governance-Paradox?, in: Gunnar Folke Schuppert & Michael Zürn (Hrsg.), Governance in einer sich wandelnden Welt, Wiesbaden: VS Verlag für Sozialwissenschaften, 118-131. Google Scholar öffnen doi.org/10.1007/978-3-531-91066-6_6
  68. Botzem, Sebastian (2002), Governance-Ansätze in der Steuerungsdiskussion: Steuerung und Selbstregulierung unter den Bedingungen fortschreitender Internationalisierung Discussion Paper, FS I 02 -106, Berlin: Wissenschaftszentrum Berlin für Sozialforschung,. Google Scholar öffnen
  69. Bower, D. Jane & Julian C. Sulej (2007), The Indian Challenge: The Evolution of a Successful New Global Strategy in the Pharmaceutical Industry, Technology Analysis & Strategic Management, 19(5), 611-624. Google Scholar öffnen
  70. Braczyk, Hans-Joachim, Philip Cooke & Martin Heidenreich (Hrsg.) (1998), Regional Innovation Systems: The role of governances in a globalized world, London: UCL Press. Google Scholar öffnen
  71. Brooks, Sarah M. (2004), Explaining Capital Account Liberalization in Latin America: A Transitional Cost Approach, World Politics, 56(3), 389-430. Google Scholar öffnen doi.org/10.1353/wp.2004.0014
  72. Bruton, Henry (1989), Import Substitution, in: Hollis Chenery & T.N. Srinivasan (Hrsg.), Handbook of Development Economics, 2, Amsterdam: Elsevier, 1601-1644. Google Scholar öffnen doi.org/10.1016/S1573-4471(89)02017-6
  73. Business Standard (2004a), Biocon denies deaths in trials, 24.08.04. Google Scholar öffnen
  74. Business Standard (2004b), Syngene in research deal with Novartis, 01.09.04. Google Scholar öffnen
  75. Business Standard (2005), Glenmark, Teijin announce $53mn deal, Mumbai, April 26, 2005. Google Scholar öffnen
  76. Business Standard (2009), Lupin out-licenses drug to US major Salix, 06.10.09. Google Scholar öffnen
  77. Business Standard (2012), Pharma majors named in clinical trial death list, 24.07.12. Google Scholar öffnen
  78. BusinessWire (2007), Merck & Co., Inc. Statement on Brazilian Government's Decision To Issue Compulsory License for STOCRIN, 04.05.07. Google Scholar öffnen
  79. BusinessWire (2010), Dr. Reddy's and Rheoscience Announce Headline Results from First Phase III Clinical Trial of Balaglitazone (DRF 2593), 04.01.10. Google Scholar öffnen
  80. Businessworld (2010), Death of a Dream, 08.02.10, <http://www.businessworld.in/ Google Scholar öffnen
  81. news/business/pharma/death-of-a-dream/460435/page-1.html>. Google Scholar öffnen
  82. Cadila Healthcare (2013), Zydus pioneers a breakthrough with LIPAGLYN, India’s first NCE to reach the market, 05.06.13. Google Scholar öffnen
  83. Caliari, Thiago & Ricardo Ruiz (2010), Structure and Innovation in Pharmaceutical Industry in Brazil: The Impact of Generic Drugs, DRUID-DIME Academy Winter Conference 2010, Aalborg, 21.-23. Januar. Google Scholar öffnen
  84. Campos, Claudio Maggi (2006), The Salmon Farming and Processing Cluster in Southern Chile, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 109-140. Google Scholar öffnen
  85. Casas, Carmen Nila Phang Romero (2009), O complexo industrial da saúde na área farmacêutica: uma discussão sobre inovação e acesso no Brasil, Tese apresentada com vistas à obtenção do título de Doutor em Ciências na área de Saúde Pública, Rio de Janeiro: Escola Nacional de Saúde Pública. Google Scholar öffnen
  86. Cassier, Maurice (2013), Pharmaceutical Patent Law In-the-Making: Opposition and Legal Action by States, Citizens, and Generics Laboratories in Brazil and India, in: Jean-Paul Gaudillière & Volker Hess (Hrsg.), Ways of Regulating Drugs in the 19th and 20th Centuries, Basingstoke: Palgrave Macmillan. Google Scholar öffnen doi.org/10.1057/9781137291523_13
  87. Cassier, Maurice & Carlos Correa (2003), Patents, Innovation and Public Health: Brazilian Public-Sector Laboratories’ Experience in Copying AIDS Drugs, in: Jean-Paul Moatti et al. (Hrsg.), Economics of AIDS and Access to HIV/AIDS Care in Developing Countries: Issues and Challenges, Paris: ANRS, Collection Sciences Sociales et Sida, 89-107. Google Scholar öffnen
  88. Cassier, Maurice & Carlos Correa (2008), Scaling-up and reverse engineering: acquisition of industrial knowledge by copying drugs in Brazil, in: Benjamin Coriat (Hrsg.), The Political Economy of HIV/AIDS in Developing Countries: TRIPS, Public Health Systems and Free Access, Cheltenham: Edward Elgar, 130-149. Google Scholar öffnen
  89. Cassier, Maurice & Marilena Correa (2007), Intellectual Property and Public Health: Coping of HIV/aids drugs by Brazilian public and private pharmaceutical laboratories, Electronic Journal of Communication, Information and Innovation in Health, 1(1), 83-90. Google Scholar öffnen doi.org/10.3395/reciis.v1i1.38en
  90. Cechinel-Filho, Valdir (Hrsg.) (2012), Plant Bioactives and Drug Discovery: Principles, Practice, and Perspectives, Hoboken: Wiley. Google Scholar öffnen doi.org/10.1002/9781118260005
  91. Centad (2010), Competition Law and Indian Pharmaceutical Industry, New Delhi: Centre for Trade and Development. Google Scholar öffnen
  92. Chadha, Alka (2009), TRIPs and patenting activity: Evidence from the Indian pharmaceutical industry, Economic Modelling, 26(2), 499-505. Google Scholar öffnen doi.org/10.1016/j.econmod.2008.10.004
  93. Chagti, Anuradha Sharma (2007), Intellectual Property Rights and Development: Strategies for Developing Countries, Journal of Development and Social Transformation, 3, 27-35. Google Scholar öffnen
  94. Chamas, Claudia Ines (2005), Developing Innovative Capacity in Brazil to meet Health Needs, in: Ingrid Hering (Hrsg.), Innovation in Developing Countries to Meet Health Needs: Experiences of China, Brazil, South Africa and India, Oxford: The Centre for Management of IP in Health R&D, 75-111. Google Scholar öffnen
  95. Chamber of Deputies (2013), Brazil's Patent Reform: Innovation Towards National Competitiveness, Brasília: Chamber of Deputies, Center for Strategic Studies and Debates. Google Scholar öffnen
  96. Chang, Ha-Joon (2002), Kicking Away the Ladder: Development Strategy in Historical Perspective, London: Anthem Press. Google Scholar öffnen
  97. Chataway, Joanna et al. (2007), Building the Case for National Systems of Health Innovation, A Background Policy Paper prepared for NEPAD in advance of the AMCOST meeting and the African Union Summit, Pretoria: NEPAD. Google Scholar öffnen doi.org/10.1080/09537320701521465
  98. Chataway, Joanna, Dinar Kale & David Wield (2007), The Indian Pharmaceutical Industry Before and After Trips, Technology Analysis & Strategic Management, 19(5), 559-563. Google Scholar öffnen doi.org/10.1080/09537320701521267
  99. Chataway, Joanna, Joyce Tait & David Wield (2007), Frameworks for Pharmaceutical Innovation in Developing Countries: The Case of Indian pharma, Technology Analysis and Strategic Management, 19(5), 697-708. Google Scholar öffnen doi.org/10.1080/09537320701521465
  100. Chaturvedi, Kalpana & Joanna Chataway (2006), Innovation in the Post-TRIPs Regime in Indian Pharmaceutical Firms: Implications for Pharmaceutical Model, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen doi.org/10.1504/IJBIR.2006.011087
  101. Chaturvedi, Kalpana, Joanna Chataway & David Wield (2007), Policy, Markets and Knowledge: Strategic Synergies in Indian Pharmaceutical Firms, Technology Analysis & Strategic Management, 19(5), 565-588. Google Scholar öffnen doi.org/10.1080/09537320701521309
  102. Chaudhuri, Sudip (1984), Manufacturing Drugs without TNCs: Status of Indigenous Sector in India, Economic & Political Weekly, 19(30), 1341-1383. Google Scholar öffnen
  103. Chaudhuri, Sudip (2005), The WTO and India's Pharmaceuticals Industry: Patent Protection, TRIPS, and Developing Countries, Oxford: Oxford University Press. Google Scholar öffnen
  104. Chaudhuri, Sudip (2008), Is Product Patent Protection Necessary to Spur Innovation in Developing Countries?, in: Neil Weinstock Netanel (Hrsg.), The Development Agenda, Global Intellectual Property and Developing Countries, New York: Oxford University Press, 265-292. Google Scholar öffnen doi.org/10.1093/acprof:oso/9780195342109.003.0012
  105. Chaudhuri, Sudip (2007), The Gap Between Successful Innovation and Access to its Benefits: Indian Pharmaceuticals, The European Journal of Development Research, 19(1), 49-65. Google Scholar öffnen doi.org/10.1080/09578810601144293
  106. Chaves, Gabriela Costa & Maria Auxiliadora Oliveira (2007), Measuring the degree of public health sensitivity of patent legislation in the context of the WTO TRIPS Agreement, Bulletin of the World Health Organization, 85(1), 49-56. Google Scholar öffnen
  107. Chaves, Gabriela Costa, Marcela Fogaça Vieira & Renata Reis (2008), Access to medicines and intellectual property in Brazil: reflections and strategies of civil society, Sur – Revista Internacional de Direitos Humanos, 5(8), 163-189. Google Scholar öffnen doi.org/10.1590/S1806-64452008000100009
  108. Choung, Jae-Yong, Hye-Ran Hwang & Jin-Ho Choi (2000), Transition of Latecomer Firms from Technology Users to Technology Generators: Korean Semiconductor Firms, World Development, 28(5), 969-982. Google Scholar öffnen doi.org/10.1016/S0305-750X(99)00161-8
  109. Cimoli, Mario & Gabriel Porcile (2009), Sources of learning paths and technological capabilities: an introductory roadmap of development processes, Economics of Innovation and New Technology, 18(7), 675-694. Google Scholar öffnen doi.org/10.1080/10438590802564600
  110. Clinton Health Access Initiative (2013), ARV Ceiling Price List (August 2013), <http://www.clintonhealthaccess.org/news-and-information/ Google Scholar öffnen
  111. ARV-Ceiling-Price-List-May-2013>. Google Scholar öffnen
  112. CNCTIS (2004), 2ª Conferência Nacional de Ciência, Tecnologia e Inovação em Saúde, Brasília: Ministério da Saúde. Google Scholar öffnen
  113. CNS (2004), Resolução No. 338, de 6 de Maio de 2004, Diário Oficial da União - Seção 1, Brasília: Conselho Nacional de Saúde. Google Scholar öffnen
  114. Coe, Neil M. & Timothy G. Bunnell (2003), ‘Spatializing’ knowledge communities: towards a conceptualization of transnational innovation networks, Global Networks, 3(4), 437-456. Google Scholar öffnen
  115. Cohen, Jillian Clare (2006), Expanding Drug Access in Brazil, Canadian Journal of Public Health, 97(6), 15-18. Google Scholar öffnen
  116. Cohen, Jillian Clare & Kristina M. Lybecker (2005), Aids Policy and Pharmaceutical Patents: Brazil's Strategy to Safeguard Public Health, The World Economy, 28(2), 211-230. Google Scholar öffnen doi.org/10.1111/j.1467-9701.2005.00668.x
  117. Cohen, Wesley M. & Daniel A. Levinthal (1990), Absorptive Capacity: A New Perspective on Learning and Innovation, Administrative Science Quarterly, 35(1), 128-152. Google Scholar öffnen doi.org/10.2307/2393553
  118. Cooke, Philip (1993), Regional innovation networks: An evaluation of six European cases, Topos, 6, 1-30. Google Scholar öffnen
  119. Cooke, Philip (1998), Introduction: Origins of the Concept, in: Hans-Joachim Braczyk et al. (Hrsg.), Regional Innovation Systems: The role of governances in a globalized world, London: UCL Press, 2-25. Google Scholar öffnen doi.org/10.1007/978-1-4471-3985-0_1
  120. Coombs, Rod, Paolo Saviotti & Vivien Walsh (Hrsg.) (1992), Technical change and company strategies: economic and sociological perspectives, London: Academy Press. Google Scholar öffnen
  121. Coriat, Benjamin & Olivier Weinstein (2002), Organizations, firms and institutions in the generation of innovation, Research Policy, 31(2), 273-290. Google Scholar öffnen doi.org/10.1016/S0048-7333(01)00141-X
  122. Coriat, Benjamin & Olivier Weinstein (2012), Patent regimes, firms and the commodification of knowledge, Socio-Economic Review, 10(2), 267-292. Google Scholar öffnen doi.org/10.1093/ser/mwr019
  123. Correa, Carlos M. (2011), Pharmaceutical Innovation, Incremental Patenting and Compulsory Licensing, South Centre Research Paper, No. 41, Geneva: South Centre,. Google Scholar öffnen
  124. Costa, Laís Silveira, Carlos Augusto Grabois Gadelha & Antoine Metten (2012), Saúde e Desenvolvimento no Brasil: estado da arte e desafios, Resumo aprovado para apresentação pôster na VI Jornada Nacional de Economica da Saúde, Brasília, 17.-19. Oktober. Google Scholar öffnen doi.org/10.1590/S0034-89102012005000062
  125. Costinot, Arnaud (2009), An Elementary Theory of Comparative Advantage, NBER Working Paper, No. 14645, Cambridge: National Bureau of Economic Research. Google Scholar öffnen doi.org/10.3386/w14645
  126. Cozzens, Susan E. & Raphael Kaplinsky (2009), Innovation, poverty and inequality: cause, coincidence, or co-evolution?, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 57-82. Google Scholar öffnen
  127. Cozzens, Susan, Sonia Gatchair & Dhanaraj Thakur (2006), Distributional Assessment of Emerging Technologies: A Framework Analysis, James Martin Institute Working Paper, 1. Google Scholar öffnen
  128. Creswell, John W. (2003), Research Design: Qualitative, Quantitative, and Mixed Methods Approaches, Thousand Oaks: Sage. Google Scholar öffnen
  129. CSDD (2010), Outlook 2010, Boston: Tufts Center for the Study of Drug Development. Google Scholar öffnen
  130. Cullet, Philippe (2001), Patents Bill, TRIPs and Right to Health, Economic & Political Weekly, 36(43), 4049-4051. Google Scholar öffnen
  131. D'Mello, Bernard (2002), Transnational Pharmaceutical Corporations and Neo-Liberal Business Ethics in India, Journal of Business Ethics, 36(1-2), 165-185. Google Scholar öffnen doi.org/10.1023/A:1014234119562
  132. Da Gama Camara Jr, Eduardo (2013), Brazil: Prosecution Of Pharmaceutical Patents In Brazil: Tensions Between The Brazilian Patent Office And ANVISA, <http://www.mondaq.com/article.asp?articleid=253068>. Google Scholar öffnen
  133. Dahlmann, Carl (2010), Innovation Strategies in Brazil, China and India: From Imitation to Deepening Technological Capability in the South, in: Xiaolan Fu & Luc Soete (Hrsg.), The Rise of Technological Power in the South, Basingstoke: Palgrave Macmillan, 15-48. Google Scholar öffnen doi.org/10.1057/9780230276123_2
  134. Damodaran, A. (2008), Indian Patent Law in the post-TRIPS Decade: S & T Policy Appraisal, Journal of Intellectual Property Rights, 13, 414-423. Google Scholar öffnen
  135. Datta, P. T. Jyothi (2013), Health Ministry scrambles to procure TB drugs, The Hindu Business Line, 23.06.13. Google Scholar öffnen
  136. David, Paul A. & Dominique Foray (2002), An introduction to the economy of the knowledge society, International Social Science Journal, 54(171), 9-23. Google Scholar öffnen doi.org/10.1111/1468-2451.00355
  137. Davies, Louise (2002), Technical Cooperation and the International Coordination of Patentability of Biotechnological Inventions, Journal of Law and Society, 29(1), 137-162. Google Scholar öffnen doi.org/10.1111/1467-6478.00214
  138. de Brito Cruz, Carlos Henrique & Hernan Chaimovich (2010), Brazil, in: Susan Schneegans (Hrsg.), UNESCO Science Report 2010, Paris: UNESCO Publishing, 103-121. Google Scholar öffnen
  139. de Brito Cruz, Carlos Henrique & Luiz de Mello (2006), Boosting Innovation Performance in Brazil, OECD Economics Department Working Papers, No. 532, Paris: OECD Publishing. Google Scholar öffnen doi.org/10.1787/357276015553
  140. De La Rosa, Sybille & Matthias Kötter (2008), Governance(-forschung) im Kontext der Disziplinen, in: Sybille De La Rosa et al. (Hrsg.), Transdisziplinäre Governanceforschung: Gemeinsam hinter den Staat blicken, Baden-Baden: Nomos, 11-33. Google Scholar öffnen
  141. Deardoff, Alan V. (1992), Welfare Effects of Global Patent Protection, Economica, 59(233), 35-51. Google Scholar öffnen
  142. DGVN (2011), Nachhaltigkeit und Gerechtigkeit: Eine bessere Zukunft für alle, Bericht über die menschliche Entwicklung 2011, Berlin: Deutsche Gesellschaft für die Vereinten Nationen. Google Scholar öffnen
  143. Di Giorgio, Rosana Ceron (2007), From University to Industry: Technology Transfer at Unicamp in Brazil, in: Anatole Krattiger et al. (Hrsg.), Intellectual Property Management in Health and Agricultural Innovation: a handbook of best practices, Oxford: MIHR, 1747-1752. Google Scholar öffnen
  144. Diário da Saúde (2010), Brasil produzirá medicamento biotecnológico para doença de Gaucher, <http://www.diariodasaude.com.br/news.php?article= Google Scholar öffnen
  145. remedio-doenca-gaucher&id=5790>. Google Scholar öffnen
  146. Dicken, Peter (2003), Global Shift: Reshaping the Global Economic Map in the 21st Century, London: Sage. Google Scholar öffnen doi.org/10.4135/9781446216767.n2
  147. Dicken, Peter et al. (2001), Chains and networks, territories and scales: towards a relational framework for analysing the global economy, Global Networks, 1(2), 89-112. Google Scholar öffnen doi.org/10.1111/1471-0374.00007
  148. DIPP (2010), Discussion Paper: Compulsory Licencing, Department of Industrial Policy & Promotion, Government of India, Ministry of Commerce & Industry, New Delhi. Google Scholar öffnen
  149. DIPP (2013), SIA Newsletter February 2013, Department of Industrial Policy & Promotion, Government of India, Ministry of Commerce & Industry, New Delhi. Google Scholar öffnen
  150. Doloreux, David & Saeed Parto (2005), Regional innovation systems: Current discourse and unresolved issues, Technology in Society, 27(2), 133-153. Google Scholar öffnen doi.org/10.1016/j.techsoc.2005.01.002
  151. Dos Santos, L. & I. Heineck (2012), Drug utilization study in pediatric prescriptions of a university hospital in southern brazil: off-label, unlicensed and high-alert medications, Farmacia Hospitalaria, 36(4), 180-186. Google Scholar öffnen doi.org/10.1016/j.farma.2010.12.008
  152. Dosi, Giovanni (1988), The nature of the innovative process, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 221-238. Google Scholar öffnen
  153. Dosi, Giovanni & Luc Soete (1988), Technological change and international trade, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 401-431. Google Scholar öffnen
  154. Dr. Reddy's (2002), Annual Report 2001-2002, Hyderabad, <http://www.drreddys.com/investors/pdf/annualreport2002.pdf>. Google Scholar öffnen
  155. Drahos, Peter & John Braithwaite (2002), Information Feudalism, London: Earthscan Publications. Google Scholar öffnen
  156. Draude, Anke (2007), How to Capture Non-Western Forms of Governance: In Favour of an Equivalence Functionalist Observation of Governance in Areas of Limited Statehood, SFB-Governance Working Paper Series, Berlin: Research Center (SFB) 700. Google Scholar öffnen
  157. Dreyfuss, Rochelle (2009), The Role of India, China, Brazil and Other Emerging Economies in Establishing Access Norms for Intellectual Property and Intellectual Property Lawmaking, International Law and Justice Working Papers, No. 5, New York: Institute for International Law and Justice, New York University School of Law. Google Scholar öffnen doi.org/10.2139/ssrn.1442785
  158. DSF (oJ), Selling Out To MNCs: R&D Deal Between Glaxo And Ranbaxy By Amit Sen Gupta, Delhi Science Forum, <http://www.delhiscienceforum.net/ Google Scholar öffnen
  159. pharmaceuticals/245-selling-out-to-mncs-rad-deal-between-glaxo-and-ranba Google Scholar öffnen
  160. xy-by-amit-sen-gupta-.html>. Google Scholar öffnen
  161. DTOLA (2011a), Flawed agreement – BMS Matrix agreement on AIDS drug, 29.06.11. Google Scholar öffnen
  162. DTOLA (2011b), Will India go for Compulsory Licensing for providing improved access to life saving medicines?, 11.04.11. Google Scholar öffnen
  163. DTOLA (2012), BMS sues Mylan (Matrix) Labs for selling generic version of HIV drug Atazanavir to PAHO, 03.08.12. Google Scholar öffnen
  164. Eaton, Jonathan & Samuel Kortum (1995), Engines of Growth: Domestic and Foreign Sources of Innovation, NBER Working Paper Series, No. 5207, Cambridge: National Bureau of Economic Research,. Google Scholar öffnen doi.org/10.3386/w5207
  165. Ecks, Stefan (2008), Global pharmaceutical markets and corporate citizenship: the case of Novartis' anti-cancer drug Glivec, BioSocieties, 3, 165-181. Google Scholar öffnen doi.org/10.1017/S1745855208006091
  166. Economic Times (2002), Ranbaxy ends two pacts with Eli Lilly, 01.02.02. Google Scholar öffnen
  167. Economic Times (2003), Matrix reloaded with more products, 28.07.03. Google Scholar öffnen
  168. Economic Times (2005), Will Vision Garuda help Ranbaxy become a high flyer?, 15.10.05. Google Scholar öffnen
  169. Economic Times (2006a), AIDS drug Viread prices may dip soon, 04.09.06. Google Scholar öffnen
  170. Economic Times (2006b), US pharma major Mylan buys Matrix Labs, 29.08.06. Google Scholar öffnen
  171. Economic Times (2006c), Wockhardt signs in-licensing agreement with UK, 05.06.06. Google Scholar öffnen
  172. Economic Times (2011a), Failures and doubting investors have not dissuaded Glenmark Pharma's Glenn Saldanha, 22.05.11. Google Scholar öffnen
  173. Economic Times (2011b), Lupin signs strategic deal with Brazilian firm Farmanguinhos, 05.01.11. Google Scholar öffnen
  174. Economic Times (2011c), Natco Pharma files India's first compulsory licence plea, 02.08.11. Google Scholar öffnen
  175. Economic Times (2011d), No additional norms to issue compulsory drug licences, 12.04.11. Google Scholar öffnen
  176. Economic Times (2012), Emcure signs deal to manufacture Roche's anti-cancer drugs, 02.03.12. Google Scholar öffnen
  177. Economic Times (2013a), Compulsory licence likely for three cancer drugs, 14.01.13. Google Scholar öffnen
  178. Economic Times (2013b), Swiss drug major Roche to drop anti-cancer drug Herceptin patent in India, 16.08.13. Google Scholar öffnen
  179. Edquist, Charles (Hrsg.) (1997), Systems of Innovation: Technologies, Institutions and Organisations, London: Pinter. Google Scholar öffnen
  180. Edquist, Charles (2001a), The Systems of Innovation Approach and Innovation Policy: An account of the state of the art, Lead paper presented at the DRUID Conference, Aalborg, 12.-15. Juni. Google Scholar öffnen
  181. Edquist, Charles (2001b), Systems of Innovation for Development (SID), Background Paper for Chapter I: «Competitiveness, Innovation and Learning: Analytical Framework” for the UNIDO World Industrial Development Report (WIDR), 2001, Linköping: Department of Technology and Social Change, Linköping University, 31.01.01. Google Scholar öffnen
  182. Edquist, Charles (2005), Systems of Innovation: Perspectives and Challenges, in: Jan Fagerberg et al. (Hrsg.), Oxford Handbook of Innovation, Oxford: Oxford University Press, 181-208. Google Scholar öffnen
  183. Edquist, Charles & Leif Hommen (2006), Comparing National Systems of Innovation in Asia and Europe: Growth, Globalisation, Change and Policy, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen
  184. Edquist, Charles & Bengt-Åke Lundvall (1993), Comparing the Danish and Swedish Systems of Innovation, in: Richard R. Nelson (Hrsg.), National Innovation Systems: A Comparative Analysis, Oxford: Oxford University Press, 265-297. Google Scholar öffnen
  185. Eimer, Thomas R. & Susanne Lütz (2010), Developmental States, Civil Society and Public Health: Patent Regulation for HIV/AIDS Vaccines in India and Brazil, Regulation and Governance, 4(2), 135-153. Google Scholar öffnen doi.org/10.1111/j.1748-5991.2010.01074.x
  186. Eimer, Thomas R., Susanne Lütz & Verena Schüren (2013), Norm diffusion through Advocacy Coalitions: Implementing international intellectual property norms in India and Brazil, ISA 54th Annual Convention, San Francisco, 03.-07. April. Google Scholar öffnen
  187. Eimer, Thomas R. & Verena Schüren (2013), Convenient Stalemates: Why International Patent Law Negotiations continue despite Deadlock, New Political Economy, 18(4), 533-554. Google Scholar öffnen doi.org/10.1080/13563467.2013.742882
  188. Eren-Vural, Ipek (2007), Domestic contours of global regulation, Understanding the policy changes on pharmaceutical patents in India and Turkey, Review of International Political Economy, 14(1), 105-142. Google Scholar öffnen doi.org/10.1080/09692290601081079
  189. Ernst & Young Terco (2011), Doing business in Brazil, <http://www.ey.com/ Google Scholar öffnen
  190. Publication/vwLUAssets/Doing_business_in_Brazil_2011/$FILE/Doing% Google Scholar öffnen
  191. 20Business%20in%20Brazil%202011.pdf>. Google Scholar öffnen
  192. Ernst, Dieter (1994), What are the Limits to the Korean Model? The Korean Electronics Industry Under Pressure, BRIE research paper, Berkeley: University of California,. Google Scholar öffnen
  193. Ernst, Dieter (2002), Global production networks and the changing geography of innovation systems: Implications for developing countries, Economics of Innovation and New Technology, 11(6), 497-523. Google Scholar öffnen doi.org/10.1080/10438590214341
  194. Ernst, Dieter, Tom Ganiatsos & Lynn Mytelka (Hrsg.) (1998), Technological Capabilities and Export Success in East Asia, London: Routledge. Google Scholar öffnen doi.org/10.4324/9780203184226
  195. Eßer, Klaus et al. (2001), Systemische Wettbewerbsfähigkeit und Entwicklung, in: Reinold E. Thiel (Hrsg.), Neue Ansätze zur Entwicklungstheorie, Bonn: DSE/IZEP, 147-163. Google Scholar öffnen
  196. Estadão.com.br (2011), Governo faz acordo para produzir novos medicamentos, <http://www.estadao.com.br/noticias/impresso,governo-faz-acordo-para-produ Google Scholar öffnen
  197. zir-novos-medicamentos,702296,0.htm>. Google Scholar öffnen
  198. Evans, Peter (1995), Embedded Autonomy: States and Industrial Transformation, Princeton: Princeton University Press. Google Scholar öffnen
  199. EXIM Bank of India (2007), Indian Pharmaceutical Industry: Surging Globally, Occasional Paper, No. 119, Mumbai: Export-Import Bank of India,. Google Scholar öffnen
  200. Expressindia (2000), Wockhardt, German partner unveil vaccine for hepatitis-B, 13.03.00. Google Scholar öffnen
  201. Expressindia (2001), Allergan, Nicholas Piramal to strengthen JV, 28.03.01. Google Scholar öffnen
  202. Fagerberg, Jan (1996), Technology and competitiveness, Oxford Review of Economic Policy, 12(3), 39-51. Google Scholar öffnen doi.org/10.1093/oxrep/12.3.39
  203. Fagerberg, Jan & Martin Srholec (2008), National innovation systems, capabilities and economic development, Research Policy, 37(9), 1417-1435. Google Scholar öffnen doi.org/10.1016/j.respol.2008.06.003
  204. Feinson, Stephen (2003), National Innovation Systems Overview and Country Cases, in: CSPO et al. (Hrsg.), Knowledge Flows and Knowledge Collectives: Understanding The Role of Science and Technology Policies in Development, Volume 1: Knowledge Flows, Innovation, and Learning in Developing Countries, New York: Global Inclusion Program of the Rockefeller Foundation, 13-38. Google Scholar öffnen
  205. Ferrer, Marcela et al. (2004), The scientific muscle of Brazil’s health biotechnology, Nature Biotechnology, 22(12s), DC8 - DC12. Google Scholar öffnen doi.org/10.1038/nbt1204supp-DC8
  206. Ferro do Lago, Regina & Nilson do Rosário Costa (2009), Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program, Cadernos de Saúde Pública, 25(10), 2273-2284. Google Scholar öffnen doi.org/10.1590/S0102-311X2009001000017
  207. FierceBiotech (2008), Wockhardt takes huge strides towards In-licensing and collaborative agreements, 10.10.08. Google Scholar öffnen
  208. Filho, Jorge Elisa Kalil (2011), Panorama regulatório da pesquisa no Brasil, in: Ricardo Ubiraci Sennes & Antonio Britto Filho (Hrsg.), Inovações tecnológicas no Brasil, São Paulo: Cultura Acadêmica, 233-266. Google Scholar öffnen
  209. Filho, Pedro Lins Palmeira & Luciana Xavier de Lemos Capanema (2010), A Cadeia Farmacêutica Nacional E O Desafio Da Inovação: Possibilidades Para A Atuação Do Bndes E Outros Agentes, XXX Encontro Nacional De Engenharia De Produção, São Carlos, 07. September. Google Scholar öffnen
  210. Finanznachrichten (2006), Dr. Reddy's, ClinTec pen cancer drug pact, 27.09.06. Google Scholar öffnen
  211. Fiocruz (2011), Medicamento para pacientes transplantados, Google Scholar öffnen
  212. <http://www2.far.fiocruz.br/farmanguinhos/index.php?option=com_content&view=article&id=298:farmanguinhos-vai-produzir-medicamento-para-pacien Google Scholar öffnen
  213. tes-transplantados&catid=53:outras-noticias&Itemid=94>. Google Scholar öffnen
  214. Firstpost (2012), Cipla’s brave act: Will cancer treatment go the AIDS way?, 12.11.12, <http://www.firstpost.com/business/ciplas-brave-act-will-cancer-treat Google Scholar öffnen
  215. ment-go-the-aids-way-523057.html>. Google Scholar öffnen
  216. Floricel, Serghei, John Michela & Mark George (2009), Resource Feedbacks for Continuous Innovation: The Articulation of Firm, University, and Government Roles, Summer Conference 2009 on Copenhagen Business School, Frederiksberg, 17.-19. Juni. Google Scholar öffnen
  217. Flynn, Matthew (2008), Public Production of Anti-Retroviral Medicines in Brazil, 1990-2007, Development and Change, 39(4), 513-536. Google Scholar öffnen doi.org/10.1111/j.1467-7660.2008.00494.x
  218. Focus Reports (2012), Brazil: Pharma Report, <http://issuu.com/focusreports/docs/ Google Scholar öffnen
  219. phex_brazil_2012>. Google Scholar öffnen
  220. Folha de S.Paulo (2012), Novartis e Furp fecham acordo de transferência, 09.11.12. Google Scholar öffnen
  221. Fransman, Martin (1984), Technological Capability in the Third World: An Overview and Introduction to some of the Issues raised in this Book, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London: Macmillan, 3-30. Google Scholar öffnen doi.org/10.1007/978-1-349-17487-4_1
  222. Freeman, Chris (1995), The 'National System of Innovation' in historical perspective, Cambridge Journal of Economics, 19(1), 5-24. Google Scholar öffnen
  223. Freeman, Christopher (1982), The Economics of Industrial Innovation, Cambridge: MIT Press. Google Scholar öffnen
  224. Freeman, Christopher (1987), Technology Policy and Economic Performance: Lessons from Japan, London: Pinter. Google Scholar öffnen
  225. Freeman, Christopher (1988), Japan: a new national system of innovation?, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 330-348. Google Scholar öffnen
  226. Frew, Sarah E. et al. (2007), India's health biotech sector at a crossroads, Nature Biotechnology, 25(4), 403-528. Google Scholar öffnen doi.org/10.1038/nbt0407-403
  227. Fritz, Barbara (1999), Implikationen der Asienkrise für das lateinamerikanische Entwicklungsmodell der 90er Jahre, Lateinamerika. Analysen-Daten-Dokumen¬tationen, 16(40), 17-31. Google Scholar öffnen
  228. Fromhold-Eisebith, Martina (2006), Effectively linking international, national, and regional innovation systems: insights from India and Indonesia, in: Bengt-Åke Lundvall et al. (Hrsg.), Asia’s Innovation Systems in Transition, Cheltenham: Edward Elgar, 75-99. Google Scholar öffnen
  229. Fu, Xiaolan, Carlo Pietrobelli & Luc Soete (2011), The Role of Foreign Technology and Indigenous Innovation in the Emerging Economies: Technological Change and Catching Up, World Development, 39(7), 1204-1212. Google Scholar öffnen doi.org/10.1016/j.worlddev.2010.05.009
  230. Furtado, Celso (1970), Economic Development of Latin America: A Survey from Colonial Times to the Cuban Revolution, Oxford: Oxford University Press. Google Scholar öffnen
  231. Gadelha, Carlos (2011), A Perspectiva do Complexo Industrial da Saúde: o desenvolvimento industrial e científico do setor e rumos para a assistência farmacêutica, Seminário Valor Econômico Perspectivas do Setor Saúde no Brasil, São Paulo: Valor Econômico S.A., 16. März. Google Scholar öffnen
  232. Galli, Riccardo & Morris Teubal (1997), Paradigmatic Shifts in National Innovation Systems, in: Charles Edquist (Hrsg.), Systems of Innovation: Technologies, Institutions and Organisations, London: Pinter, 342-370. Google Scholar öffnen
  233. George, Alexander L. & Andrew Bennett (2005), Case Studies and Theory Development in the Social Sciences, Cambridge: MIT Press. Google Scholar öffnen
  234. George, Julie, Ramaya Sheshadri & Anand Grover (2009), Intellectual Property and Access to Medicines: Developments and Civil Society Initiatives in India, in: Renata Reis et al. (Hrsg.), Intellectual Property Rights and Access to ARV Medicines: Civil Society Resistance in the Global South, Rio de Janeiro: Brazilian Interdisciplinary AIDS Association, 110-136. Google Scholar öffnen
  235. Gereffi, Gary (1999), International Trade and Industrial Upgrading in the Apparel Commodity Chain, Journal of International Economics, 48(1), 37-70. Google Scholar öffnen doi.org/10.1016/S0022-1996(98)00075-0
  236. Gereffi, Gary (2014), Global value chains in a post-Washington Consensus world, Review of International Political Economy, 21(1), 9-37. Google Scholar öffnen doi.org/10.1080/09692290.2012.756414
  237. Gereffi, Gary, John Humphrey & Timothy Sturgeon (2005), The governance of global value chains, Review of International Political Economy, 12(1), 78-104. Google Scholar öffnen doi.org/10.1080/09692290500049805
  238. Gerring, John (2004), What Is a Case Study and What Is It Good for?, American Political Science Review, 98(2), 341-354. Google Scholar öffnen doi.org/10.1017/S0003055404001182
  239. Gerring, John (2007), Case Study Research: Principles and Practices, Cambridge: Cambridge University Press. Google Scholar öffnen
  240. Gilead Sciences (2011), Gilead Expands Access Program for Medications in Developing World, 12.07.11. Google Scholar öffnen
  241. Gilead Sciences (2013), Scaling Up Antiretroviral Treatment Sustainably: Gilead Sciences Programs in Developing Countries, November 2013. Google Scholar öffnen
  242. GIPI (2012), Relatório de Análise e Sugestão de Critérios, Mecanismos, Procedimentos, Obrigações e Possíveis Instrumentos Formais para Articulação Entre a Anvisa e o Inpi com Vistas à Execução do Art. 229-C da Lei No. 9.279/1996, Brasília: Grupo Interministerial de Propriedade Intelectual, 19. Januar. Google Scholar öffnen
  243. Girtler, Roland (2001), Methoden der Feldforschung, Wien: Böhlau. Google Scholar öffnen
  244. Girvan, Norman P. (1987), Transnational corporations and non-fuel primary commodities in developing countries, World Development, 15(5), 713-740. Google Scholar öffnen doi.org/10.1016/0305-750X(87)90013-1
  245. Giugale, Marcelo (2011), Yes, They Can: How Emerging Economies Are Building Universal Health Coverage, Huffington Post, 05.07.11. Google Scholar öffnen
  246. Giuliani, Elisa, Carlo Pietrobelli & Roberta Rabellotti (2005), Upgrading in Global Value Chains: Lessons from Latin American Clusters, World Development, 33(4), 549-573. Google Scholar öffnen doi.org/10.1016/j.worlddev.2005.01.002
  247. Gläser, Jochen & Grit Laudel (2004), Experteninterviews und qualitative Inhaltsanalyse, Wiesbaden: VS Verlag für Sozialwissenschaften. Google Scholar öffnen
  248. globo.com (2008), INPI nega patente ao anti-retroviral Tenofovir, 02.09.08. Google Scholar öffnen
  249.   Google Scholar öffnen
  250. Gontijo, Cicero (2005), Die Veränderungen im Patentsystem: Von der Pariser Verbandsübereinkunft zum TRIPS-Abkommen. Die Position Brasiliens, in: Thomas Fritz et al. (Hrsg.), Produktion der Abhängigkeit: Wertschöpfungsketten. Investitionen. Patente, Berlin: Forschungs- und Dokumentationszentrum Chile - Lateinamerika e.V., 79-100. Google Scholar öffnen
  251. Gopakumar, K.M. (2010), India: A Critical Review of the Implementation of TRIPS Patent Regime, The Law and Development Review, 3(2), 324-368. Google Scholar öffnen
  252. Gouveia, Roberto (2005), Parliamentary Bill 22/03, Brazil, National Congress. Google Scholar öffnen
  253. Gräbe, Hans-Gert (2005), Die Macht des Wissens in der modernen Gesellschaft, Utopie kreativ,(177/178), 629-643. Google Scholar öffnen
  254. Granstrand, Ove (2005), Innovation and Intellectual Property Rights, in: Jan Fagerberg et al. (Hrsg.), The Oxford Handbook of Innovation, Oxford: Oxford University Press, 266-290. Google Scholar öffnen
  255. Granstrand, Ove (2011), The economics of IP in the context of a shifting innovation paradigm, Contribution to the WIPO Innovation Report 2011 «Shifting Innovation Paradigms and the Role of Intellectual Property”, May. Google Scholar öffnen
  256. Greenhalgh, Christine & Mark Rogers (2010), Innovation, Intellectual Property, and Economic Growth, Princeton: Princeton University Press. Google Scholar öffnen doi.org/10.2307/j.ctt1zgwjjb
  257. Grosse Ruse-Khan, Henning (2009), Policy Space for Domestic Public Interest Measures Under TRIPS, South Centre Research Papers, No. 22, Geneva: The South Centre, Juli 2009. Google Scholar öffnen
  258. Grover, Anand (2013), Analysing the Supreme Court Judgment, Economic & Political Weekly, 44(32), 46-49. Google Scholar öffnen
  259. Gualini, Enrico (2006), Mehrebenen-Governance und neue Formen von Territorialität, in: Ralf Kleinfeld et al. (Hrsg.), Regional Governance: Steuerung, Koordination und Kommunikation in regionalen Netzwerken als neue Formen des Regierens, Düsseldorf: V&R Unipress, 61-82. Google Scholar öffnen
  260. Guellec, Dominique (2007), Patents as an Incentive to Innovate, in: Dominique Guellec & Bruno van Pottelsberghe de la Potterie (Hrsg.), The Economics of the European Patent System: IP Policy for Innovation and Competition, Oxford: Oxford University Press, 46-84. Google Scholar öffnen doi.org/10.1093/acprof:oso/9780199216987.003.0003
  261. Guennif, Samira & Shyama V. Ramani (2010), Catching up in pharmaceuticals: a comparative study of India and Brazil, UNU-MERIT Working Papers, No. 19, Maastricht: United Nations University. Google Scholar öffnen
  262. Guennif, Samira & Shyama V. Ramani (2012), Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework, Research Policy, 41(2), 430-441. Google Scholar öffnen doi.org/10.1016/j.respol.2011.09.005
  263. Guise Rosina, Monica Steffen, Daniel Wei Liang Wang & Thana Cristina de Campos (2010), Access to Medicines: Pharmaceutical Patents and the Right to Health in: Lea Shaver (Hrsg.), Access to Knowledge in Brazil: New Research on Intellectual Property, Innovation and Development, London: Bloomsbury, 103-134. Google Scholar öffnen
  264. Hall, Peter A. (2003), Aligning Ontology and Methodology in Comparative Research, in: James Mahoney & Dietrich Rueschemeyer (Hrsg.), Comparative Historical Analysis in the Social Sciences, Cambridge: Cambridge University Press, 373-404. Google Scholar öffnen doi.org/10.1017/CBO9780511803963.012
  265. Hall, Peter A. & Kathleen Thelen (2009), Institutional change in varieties of capitalism, Socio-Economic Review, 7(1), 7-34. Google Scholar öffnen
  266. Hartmann, Jürgen (1995), Vergleichende Politikwissenschaft: Ein Lehrbuch, Frankfurt: Campus. Google Scholar öffnen
  267. Hasenclever, Lia & Julia Paranhos (2009), The development of the pharmaceutical industry in Brazil and India: technological capability and industrial development, Rio de Janeiro: Federal University, Economics Institute. Google Scholar öffnen
  268. Hassan, Emmanuel, Ohid Yaqub & Stephanie Diepeveen (2010), Intellectual Property and Developing Countries: A review of the literature, Technical Reports, TR-804-IPO, Santa Monica: RAND Corporation. Google Scholar öffnen
  269. Hausmann, Ricardo & Bailey Klinger (2007), The Structure of the Product Space and the Evolution of Comparative Advantage, CID Working Paper, No. 146, Cambridge: Center for International Development at Harvard University. Google Scholar öffnen
  270. Hein, Wolfgang (1998), Unterentwicklung – Krise der Peripherie: Phänomene, Theorien, Strategien, Opladen: Leske + Budrich. Google Scholar öffnen doi.org/10.1007/978-3-663-11692-9_7
  271. Hemmer, Hans-Rimbert & Rainer Wilhelm (2001), Neue Hoffnung für Entwicklungsländer? Entwicklungspolitische Implikationen endogener Wachstumstheorien, in: Reinold E. Thiel (Hrsg.), Neue Ansätze zur Entwicklungstheorie, Bonn: Deutsche Stiftung für internationale Entwicklung, 249-258. Google Scholar öffnen
  272. Herring, Ronald J. (1999), Embedded Particularism: India's Failed Devleopmental State, in: Meredith Woo-Cumings (Hrsg.), The Developmental State, Ithaca: Cornell University Press, 306-332. Google Scholar öffnen
  273. Herrmann, Margaret G. (2008), Content Analysis, in: Audie Klotz & Deepa Prakash (Hrsg.), Qualitative Methods in International Relations: A Pluralist Guide, Basingstoke: Palgrave Macmillan, 151-167. Google Scholar öffnen
  274. Hirschman, Albert O. (1958), The Strategy of Economic Development, New Haven: Yale University Press. Google Scholar öffnen
  275. Hobday, Michael (1995), Innovation in East Asia: The Challenge to Japan, Aldershot: Edward Elgar. Google Scholar öffnen doi.org/10.4337/9781781954201.00014
  276. Hoffmann, Jean (2005), Generics Growth in the USA and the EU: The Role of India, Journal of Generic Medicines, 3(1), 7-19. Google Scholar öffnen
  277. Hollingsworth, J. Rogers & Robert Boyer (Hrsg.) (1997), Contemporary Capitalism: The Embeddedness of Institutions, Cambridge: Cambridge University Press. Google Scholar öffnen doi.org/10.1017/CBO9781139174701
  278. Hooda, Shailender Kumar (2013), Changing Pattern of Public Expenditure on Health in India: Issues and Challenges, Working Paper Series, No. 01, New Delhi: ISID-PHFI Collaborative Research Centre Institute for Studies in Industrial Development. Google Scholar öffnen
  279. Horner, Rory (2013), The Impact of Patents on Innovation, Technology Transfer and Health: A Pre- and Post-TRIPs Analysis of India's Pharmaceutical Industry, New Political Economy, DOI:10.1080/13563467.2013.796446. Google Scholar öffnen doi.org/10.1080/13563467.2013.796446
  280. Howells, Jeremy (1999), Regional systems of innovation?, in: Daniele Archibugi et al. (Hrsg.), Innovation Policy in a Global Economy, Cambridge: Cambridge University Press, 67-93. Google Scholar öffnen doi.org/10.1017/CBO9780511599088.007
  281. HP (2012), CSIR and HP announce the launch of a rapidly deployable and fully integrated cloud-enabled eHealth Centre, 11.12.12. Google Scholar öffnen
  282. Hubaceka, Klaus, Dabo Guana & Anamika Baruaa (2007), Changing lifestyles and consumption patterns in developing countries: A scenario analysis for China and India, Futures, 39(9), 1084-1096. Google Scholar öffnen
  283. Huibo, Zhong & Zheng Bingwen (2011), Comparison of Government Functions of BRIC in «National Innovation System”: From the Degree of Homoplasy and Embeddedness, in: Li Yang (Hrsg.), BRICs & the global transformation: Considerations on the BRIC Summit of Think Tanks in Brasilia, Reading: Social Sciences Academic Press, 139-165. Google Scholar öffnen
  284. Humphrey, John & Hubert Schmitz (2000), Governance and Upgrading: Linking Industrial Cluster and Global Value Chain Research, Institute of Development Studies, IDS Working Paper 120, Brighton: University of Sussex,. Google Scholar öffnen
  285. Humphrey, John & Hubert Schmitz (2002), How does insertion in global value chains affect upgrading in industrial clusters?, Regional Studies, 36(9), 1017-1027. Google Scholar öffnen doi.org/10.1080/0034340022000022198
  286. IBGE (2010), Pesquisa de Inovação Tecnológica, Instituto Brasileiro de Geografia e Estatística, Ministério do Planejamento, Orçamento e Gestão, Rio de Janeiro. Google Scholar öffnen
  287. ICIS news (2003), Matrix rejects Lundbeck's DKr300m offer to halt production, 14.02.03. Google Scholar öffnen
  288. ICRA (2011), CRAMS India: Overview & Outlook, Juni 2011, <http://www.icra.in/ Google Scholar öffnen
  289. Files/Articles/CRAMS%20Note,%20Overview%20and%20Outlook.pdf>. Google Scholar öffnen
  290. IMF (2003), World Economic Outlook April 2003: Growth and Institutions, Washington, D.C.: International Monetary Fund. Google Scholar öffnen
  291. India Daily (2007), A new trend in emerging nations - Brazil opts for Indian generic drug ignoring US pharmaceutical giant Merck’s patent on AIDS drug Efavirenz, 06.05.07. Google Scholar öffnen
  292. IP Health (2006), Brazil consideration of compulsory license of Viread patents, 22.12.06. Google Scholar öffnen
  293. IP Health (2012), Ip-health Digest, Ip-health Digest, 29(16). Google Scholar öffnen
  294. IP Tango (2009), Brazilian PPPs in the Pharma Industry, 06.04.09. Google Scholar öffnen
  295. IP Tango (2011), Brazil and the antidepressant market: changing the mood, 23.08.11. Google Scholar öffnen
  296. IP Watch (2008), US, Indian HIV/AIDS Drug Rulings Could Reverberate In Brazil, 04.07.08. Google Scholar öffnen
  297. IP Watch (2010), Inside Views: Big Pharma Stranglehold: Thwarting India As Independent Maker Of Blockbuster HIV Drugs?, 28.10.10. Google Scholar öffnen
  298. IP Watch (2012), India Grants First Compulsory Licence, For Bayer Cancer Drug, 12.03.2012. Google Scholar öffnen
  299. IP Watch (2013), Inside Views: The Novartis Decision: A Tale Of Developing Countries, IP, And The Role Of The Judiciary, 15.04.13. Google Scholar öffnen
  300. IPR (2010), Indian President Patil speaks at Inauguration of National Seminar on Recent Trends in Pharmacy Education and Practice, New Delhi: The Office of President of India, 09.07.10. Google Scholar öffnen
  301. Jaffe, Adam B. & Josh Lerner (2004), Innovation and Its Discontents: How Our Broken Patent System is Endangering Innovation and Progress, and What to Do About It, Princeton: Princeton University Press. Google Scholar öffnen
  302. Jahn, Detlef (2005), Fälle, Fallstricke und die komparative Methode in der vergleichenden Politikwissenschaft, in: Sabine Kropp & Michael Minkenberg (Hrsg.), Vergleichen in der Politikwissenschaft, Wiesbaden: VS Verlag für Sozialwissenschaften, 55-75. Google Scholar öffnen doi.org/10.1007/978-3-322-80441-9_3
  303. Jeffrey, Roger & MR Santhosh (2009), Architecture of Drug Regulation in India. What are the Barriers to Regulatory Reform?, Journal of Health Studies, 2(1-3), 13-31. Google Scholar öffnen
  304. Johnson, Björn, Charles Edquist & Bengt-Åke Lundvall (2003), Economic Development and the National System of Innovation Approach, 1st GLOBELICS Conference: Innovation Systems and Development Strategies for the Third Millennium, Rio de Janeiro, 03.-06. November. Google Scholar öffnen
  305. Johnson, Björn & Bengt-Åke Lundvall (2003), Promoting innovation systems as a response to the globalizing learning economy, in: José E. Cassiolato et al. (Hrsg.), Systems of Innovation: Evidence from Brazil, Cheltenham: Edward Elgar, 141-184. Google Scholar öffnen doi.org/10.4337/9781781009895.00014
  306. Joyce, Joseph P. & Ilan Noy (2005), The IMF and the Liberalization of Capital Flows, East-West Center Working Papers, Economics Series, Honolulu: East-West Center,. Google Scholar öffnen doi.org/10.2139/ssrn.825652
  307. Juma, Calestous et al. (2001), Global governance of technology: meeting the needs of developing countries, International Journal of Technology Management, 22(7/8), 629-655. Google Scholar öffnen doi.org/10.1504/IJTM.2001.002982
  308. Kaiser Health News (2005), Brazil Requests Voluntary Licensing for AIDS Drugs To Treat More Patients, Reduce Costs of Importing Patented Drugs, 16.03.05. Google Scholar öffnen
  309. Kale, Dinar & Steve Little (2007), From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry, Technology Analysis & Strategic Management, 19(5), 589-609. Google Scholar öffnen doi.org/10.1080/09537320701521317
  310. Kapczynski, Amy (2009), Harmonization and Its Discontents: A case Study of TRIPS Implementation in India's Pharmaceutical Sector, California Law Review, 97, 1571-1650. Google Scholar öffnen
  311. Kapczynski, Amy (2013), Engineered in India — Patent Law 2.0, The New England Journal of Medicine, 369(6), 497-499. Google Scholar öffnen doi.org/10.1056/NEJMp1304400
  312. Kaplinsky, Raphael (2000), Globalisation and Unequalisation: What Can Be Learned from Value Chain Analysis?, Journal of Development Studies, 37(2), 117-146. Google Scholar öffnen doi.org/10.1080/713600071
  313. KEI (2012), KEI Statement on India's granting of compulsory license to patents on cancer drug sorafenib (NATCO Vs. BAYER), James Love's blog, Knowledge Ecology International, 12.03.12. Google Scholar öffnen
  314. Kessler, Eric H. & Alok K. Chakrabarti (1996), Innovation Speed: A Conceptual Model of Context, Antecedents, and Outcomes, The Academy of Management Review, 21(4), 1143-1191. Google Scholar öffnen doi.org/10.2307/259167
  315. Khader, Feroz Ali (2007), The Law of Patents - With a Special Focus on Pharmaceuticals in India, New Delhi: LexisNexis Butterworths. Google Scholar öffnen
  316. Kim, Linsu (1997), Imitation to Innovation: the Dynamics of Korea’s Technological Learning, Boston: Harvard Business School Press. Google Scholar öffnen
  317. Kim, Linsu (1999), Learning And Innovation In Economic Development, Cheltenham: Edward Elgar. Google Scholar öffnen
  318. King, Gary, Robert O. Keohane & Sidney Verba (1994), Designing Social Inquiry: Scientific Inference in Qualitative Research, Princeton: Princeton University Press. Google Scholar öffnen
  319. Kiran, Ravi & Sunita Mishra (2009), Changing Pragmatics of the Indian Pharmaceutical Industry in the Pre and Post TRIPS Period, International Journal of Business and Management, 4(9), 206-220. Google Scholar öffnen doi.org/10.5539/ijbm.v4n9p206
  320. Klein, Helena Espellet, Lia Hasenclever & Carlos José Saldanha Machado (2011), Regulação e Difusão de Tecnologias e sua Influência na Capacitação Tecnológica em Saúde Dos Países em Desenvolvimento, Revista Brasileira de Ciência, Tecnologia e Sociedade, 2(2), 130-149. Google Scholar öffnen
  321. Koeller, Priscila & José Luis Gordon (2013), Brazil, in: Mario Scerri & Helena M. M. Lastres (Hrsg.), The Role of the State, New Delhi: Routledge, 23-79. Google Scholar öffnen
  322. Korzeniewicz, Roberto Patricio (2012), Trends in World Income Inequality and the ‘Emerging Middle, European Journal of Development Research, 24(2), 205-222. Google Scholar öffnen doi.org/10.1057/ejdr.2012.2
  323. Krishna, V. V. (2013), India, in: Mario Scerri & Helena M. M. Lastres (Hrsg.), The Role of the State, New Delhi: Routledge, 138-187. Google Scholar öffnen
  324. Krugman, Paul (2009), How Did Economists Get It So Wrong?, The New York Times Sunday Magazine, 06.09.09. Google Scholar öffnen
  325. Kuckartz, Udo (2009), Inhaltsanalyse, in: Bettina Westle (Hrsg.), Methoden der Politikwissenschaft, Baden-Baden: Nomos, 334-344. Google Scholar öffnen
  326. Kuhrt, Nicola (2012), Klinische Studien in Indien: Erst der Test, dann die Moral, Spiegel Online, 09.05.2012. Google Scholar öffnen
  327. Kumar, Nagesh (1998), Technology Generation and Technology Transfer in the World Economy, Science Technology Society, 3, 265-306. Google Scholar öffnen doi.org/10.1177/097172189800300201
  328. Kurtz, Marcus J. & Sarah M. Brooks (2008), Embedding Neoliberal Reform in Latin America, World Politics, 2(1), 231-280. Google Scholar öffnen doi.org/10.1353/wp.0.0015
  329. Lachmann, Werner (2004), Entwicklungspolitik. Band 1: Grundlagen, 1, München: Oldenbourg. Google Scholar öffnen doi.org/10.1524/9783486599527
  330. Laforgia, Francesco, Fabio Montobbio & Luigi Orsenigo (2009), IPRs and Technological Development in Pharmaceuticals. Who is patenting what in Brazil after TRIPS?, in: Neil Weinstock Netanel (Hrsg.), The Development Agenda: Global Intellectual Property and Developing Countries, New York: Oxford University Press, 293-319. Google Scholar öffnen
  331. Lal, Harivansh (1990), Drugs industry, social responsibility, and the multinationals, New Delhi: Commonwealth Publishers. Google Scholar öffnen
  332. Lall, Sanjaya (1992), The Role of Technology in Economic Development, in: Simon Teitel (Hrsg.), Towards a New Development Strategy for Latin America: Pathways from Hirschman's Thought, Washington, D.C.: John Hopkins University Press, 169-218. Google Scholar öffnen
  333. Lall, Sanjaya (1998), Technological capabilities in emerging Asia, Oxford Agrarian Studies, 26(2), 213-243. Google Scholar öffnen doi.org/10.1080/13600819808424154
  334. Lall, Sanjaya (1999), India's Manufactured Exports: Comparative Structure and Prospects, World Development, 27(10), 1769-1786. Google Scholar öffnen doi.org/10.1016/S0305-750X(99)00084-4
  335. Landes, W. & R. Posner (2003), The economic structure of intellectual property law, Cambridge: The Belkup Press of Harvard University Press. Google Scholar öffnen
  336. Landesmann, Michael & Robert Stehrer (2004), Global Growth Processes: Technology Diffusion, Catching-up and Effective Demand, wiiw Working Paper, No. 26, Wien: Wiener Institut für Internationale Wirtschaftsvergleiche, Januar. Google Scholar öffnen doi.org/10.3406/rei.2004.3034
  337. Lastres, Helena Maria Martins, José E. Cassiolato & Maria Lucia Maciel (2003), Systems of innovation for development in the knowledge era: an introduction, in: José E. Cassiolato et al. (Hrsg.), Systems of Innovation and Development, Evidence from Brazil, Cheltenham: Edward Elgar, 1-34. Google Scholar öffnen
  338. Lettington, Robert & Mita Manek (1998), "Pandora's Box": TRIPS Article 27 (3) (b) and the CBD, <http://www.iatp.org/files/Pandoras_Box_TRIPs_Article_ Google Scholar öffnen
  339. 273b_and_the_CBD.htm>. Google Scholar öffnen
  340. Levin, Richard C. et al. (1987), Appropriating the Returns from Industrial Research and Development, Brookings Papers on Economic Activity (3: Microeconomics), 783-831. Google Scholar öffnen doi.org/10.2307/2534454
  341. Lewis, W. Arthur (1954), Economic Development with Unlimited Supplies of Labour, The Manchester School, 22(2), 139-191. Google Scholar öffnen doi.org/10.1111/j.1467-9957.1954.tb00021.x
  342. Li, Xuan (2008), The Impact of Higher Standards in Patent Protection for Pharmaceutical Industries under the TRIPS Agreement: A Comparative Study of China and India, UNU-WIDER Research Paper, No. 36, Helsinki: UNU World Institute for Development Economics Research,. Google Scholar öffnen doi.org/10.1111/j.1467-9701.2008.01133.x
  343. Lijphart, Arend (1971), Comparative politics and the comparative method, American Political Science Review, 65(3), 682-693. Google Scholar öffnen doi.org/10.2307/1955513
  344. Lijphart, Arend (1975), The Comparable-Cases Strategy in Comparative Research, Comparative Political Studies, 8(2), 158-177. Google Scholar öffnen doi.org/10.1177/001041407500800203
  345. Lind, Hans-Günter & Pedro Gouveia (2012), The Life Sciences Industry in Brazil, Working Paper, Leipzig: Fraunhofer-Zentrum für Mittel- und Osteuropa. Google Scholar öffnen
  346. Lipietz, Alain (1987), Mirages and Miracles: The Crisis of Global Fordism, London: Verso. Google Scholar öffnen
  347. List, Friedrich (1841), Das Nationale System der Politischen Ökonomie, Basel: Kyklos. Google Scholar öffnen
  348. Liu, Xielin & Steven White (2001), Comparing innovation systems: a framework and application to China’s transitional context, Research Policy, 30(7), 1091-1114. Google Scholar öffnen doi.org/10.1016/S0048-7333(00)00132-3
  349. Livemint (2008), Natco withdraws plea on making patented cancer drugs, 28.09.08. Google Scholar öffnen
  350. Livemint (2009), CSIR lab in second licensing deal with US pharma company, 22.02.09. Google Scholar öffnen
  351. Livemint (2012), Bayer asked to give cost data, 13.01.12. Google Scholar öffnen
  352. Love, James Packard (2007), Recent examples of compulsory licensing of patents, KEI Research Note, No. 2, Washington, D.C.: Knowledge Ecology International. Google Scholar öffnen
  353. Lu, Bingbin (2011), Best Mode Disclosure for Patent Applications: An International and Comparative Perspective, Journal of Intellectual Property Rights, 16(5), 409-417. Google Scholar öffnen
  354. Lundvall, Bengt-Åke (1992), National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, London: Pinter. Google Scholar öffnen
  355. Lundvall, Bengt-Åke (2007), National Innovation Systems: Analytical Concept and Development Tool, Industry and Innovation, 14(1), 95-119. Google Scholar öffnen doi.org/10.1080/13662710601130863
  356. Lundvall, Bengt-Åke, Patarapong Intarakumnerd & Jan Vang (2006), Asia’s Innovation Systems in Transition: An Introduction, in: Bengt-Åke Lundvall et al. (Hrsg.), Asia’s Innovation Systems in Transition, Cheltenham: Edward Elgar, 1-20. Google Scholar öffnen doi.org/10.4337/9781847201737
  357. Lundvall, Bengt-Åke et al. (2002), National systems of production, innovation and competence building, Research Policy, 31, 213-231. Google Scholar öffnen doi.org/10.1016/S0048-7333(01)00137-8
  358. Lundvall, Bengt-Åke et al. (2009), Innovation System Research and Developing Countries, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 1-30. Google Scholar öffnen doi.org/10.4337/9781849803427.00006
  359. Lütz, Susanne (2003), Governance in der politischen Ökonomie, MPIfG Discussion Paper, No. 5, Köln: Max-Planck-Institut für Gesellschaftsforschung. Google Scholar öffnen
  360. Mahajan, Madhur Mohit (2011), The Emergence of New R&D Paradigms in the Indian Pharmaceutical Industry: Post TRIPS Period, Journal of Intellectual Property Rights, 16(4), 321-329. Google Scholar öffnen
  361. Mahoney, James (2000), Path dependence in historical sociology, Theory and Society, 29(4), 507-548. Google Scholar öffnen doi.org/10.1023/A:1007113830879
  362. Malerba, Franco (2005), Sectoral Systems: How and Why Innovation Differs across Sectors, in: Jan Fagerberg et al. (Hrsg.), The Oxford Handbook of Innovation, Oxford: Oxford University Press, 380-406. Google Scholar öffnen
  363. Malerba, Franco (2006), Catch up in different sectoral systems - some introductory remarks, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen
  364. Malerba, Franco & Richard Nelson (2011), Learning and catching up in different sectoral systems: evidence from six industries, Industrial and Corporate Change, 20(6), 1645-1675. Google Scholar öffnen doi.org/10.1093/icc/dtr062
  365. Mani, Sunil (2006a), The incremental innovator versus the trader contrast between the sectoral system of innovation of the Indian pharmaceutical and telecommunication industries, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen
  366. Mani, Sunil (2006b), The Sectoral System of Innovation of Indian Pharmaceutical Industry, Working Paper, No. 382, Thiruvananthapuram: Centre for Development Studies. Google Scholar öffnen
  367.   Google Scholar öffnen
  368. Manikandan, A.D. (2006), Performance of Foreign Multinationals and Domestic Companies in India since Liberalisation: A Comparative Study, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen
  369. Marcellin, Sherry S. (2010), The Political Economy of Pharmaceutical Patents: US Sectional Interests and the African Group at the WTO, Farnham: Ashgate. Google Scholar öffnen
  370. Maskus, Keith E. (2000), Intellectual Property Rights in the Global Economy, Washington, D.C.: Institute for International Economics. Google Scholar öffnen
  371. May, Christopher (2004), Cosmopolitan legalism meets "thin community": problems in the global governance of intellectual property, Government and Opposition, 39(3), 393-422. Google Scholar öffnen doi.org/10.1111/j.1477-7053.2004.000128.x
  372. Mayntz, Renate (2002), Zur Theoriefähigkeit makro-sozialer Analysen, in: Renate Mayntz (Hrsg.), Akteure - Mechanismen - Modelle: Zur Theoriefähigkeit makro-sozialer Analysen, Frankfurt am Main: Campus, 7-43. Google Scholar öffnen
  373. Mayntz, Renate & Fritz W. Scharpf (1995), Der Ansatz des akteurzentrierten Institutionalismus, in: Renate Mayntz & Fritz W. Scharpf (Hrsg.), Gesellschaftliche Selbstregelung und politische Steuerung, Frankfurt am Main: Campus, 39-72. Google Scholar öffnen
  374. Mayntz, Renate et al. (2005), Globale Strukturen und deren Steuerung: Auswertung der Ergebnisse eines Förderprogramms der Volkswagen Stiftung, Forschungsbericht aus dem MPIfG, MPIfG Working Paper No. 5, Köln: Max-Planck-Institut für Gesellschaftsforschung. Google Scholar öffnen
  375. Mazumdar, Mainak (2013), Performance of Pharmaceutical Companies in India: A Critical Analysis of Industrial Structure, Firm Specific Resources, and Emerging Strategies, Heidelberg: Physica Verlag. Google Scholar öffnen doi.org/10.1007/978-3-7908-2876-4_6
  376. MCTI (2013), Resultado Após Análises dos Recursos, Chamada Pública MCTI / FINEP / Ação Transversal – Inova Empresa – PNI/Parques Tecnológicos 02/2013, Brasília. Google Scholar öffnen
  377. Meckstroth, Theodore W. (1975), «Most Different Systems” and «Most Similar Systems”: A Study in the Logic of Comparative Inquiry, Comparative Political Studies, 8(2), 132-157. Google Scholar öffnen doi.org/10.1177/001041407500800202
  378. Menghaney, Leena (2012), India’s patent law on trial, BMJ Group Blogs, 27.09.12. Google Scholar öffnen
  379. Menghaney, Leena (2013), ‘Drop the Case’: Campaigning against Novartis, Economic & Political Weekly, 48(32), 52-54. Google Scholar öffnen
  380. Meuser, Michael & Ulrike Nagel (2009), Experteninterview und der Wandel der Wissensproduktion, in: Alexander Bogner et al. (Hrsg.), Experteninterviews: Theorien, Methoden, Anwendungsfelder, Wiesbaden: VS Verlag für Sozialwissenschaften, 35-60. Google Scholar öffnen
  381. Mill, John Stuart (1884), A system of logic, ratiocinative and inductive: being a connected view of the principles of evidence and the methods of scientific investigation London: Routledge. Google Scholar öffnen
  382. Milstien, Julie B., Patrick Gaulé & Miloud Kaddar (2007), Access to Vaccine Technologies in Developing Countries: Brazil and India, Vaccine, 25(44), 7610-7619. Google Scholar öffnen doi.org/10.1016/j.vaccine.2007.09.007
  383. Miramontes, Eduardo Zepeda (2006), The Segusino Cluster: Boom and Bust in Furniture Exports, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 143-174. Google Scholar öffnen
  384. Mkandawire, Thandika (2007), Transformative Social Policy and Innovation in Developing Countries, The European Journal of Development Research, 19(1), 13-29. Google Scholar öffnen doi.org/10.1080/09578810601144236
  385. MoCF (2011), National Pharmaceuticals Pricing Policy 2011, Department of Pharmaceuticals, Government of India, Ministry of Chemicals & Fertilizers, New Delhi. Google Scholar öffnen
  386. MoCF (2012), Annual Report 2011-12, Department of Pharmaceuticals, Government of India, Ministry of Chemicals & Fertilizers, New Delhi. Google Scholar öffnen
  387. MoCF (2013), Drug Price Control Order, Department of Pharmaceuticals, Government of India, Ministry of Chemicals & Fertilizers, New Delhi. Google Scholar öffnen
  388. MoCI (2004), Kamal Nath's Statement on the Ordinance Relating to Patents (Third) Amendment, Press Information Bureau, Government of India, Ministry of Commerce & Industry, 27.12.04. Google Scholar öffnen
  389. MoCI (2008), Strategy for Increasing Exports of Pharmaceutical Products: Report of the Task Force, Department of Commerce, Government of India, Ministry of Commerce and Industry, New Delhi. Google Scholar öffnen
  390. Morel, Carlos et al. (2005), Health Innovation Networks to Help Developing Countries Address Neglected Diseases, Science, 309(5733), 401-404. Google Scholar öffnen doi.org/10.1126/science.1115538
  391. Morrison, Andrea (2008), Gatekeepers of Knowledge within Industrial Districts: Who They Are, How They Interact, Regional Studies, 42(6), 817-835. Google Scholar öffnen doi.org/10.1080/00343400701654178
  392. Morrison, Andrea, Carlo Pietrobelli & Roberta Rabellotti (2008), Global Value Chains and Technological Capabilities: A Framework to Study Learning and Innovation in Developing Countries, Oxford Development Studies, 36(1), 39-58. Google Scholar öffnen doi.org/10.1080/13600810701848144
  393. MoST (2011), Youngsters Should Join Innovative Scientific Research to Secure World Leadership: Deshmukh, Be Globally Competitive to have Cutting Edge Advantage: Ashwani Kumar, Press Information Bureau, Government of India, Ministry of Science & Technology, 26.09.11. Google Scholar öffnen
  394. Mowery, David C. & Joanne E. Oxley (1995), Inward Technology Transfer and Competitiveness: The Role of National Innovation Systems, Cambridge Journal of Economics, 19(1), 67-93. Google Scholar öffnen
  395. Mowery, David & Nathan Rosenberg (1998), Paths of Innovation: Technological Change in 20th-Century America, Cambridge: Cambridge University Press. Google Scholar öffnen doi.org/10.1017/CBO9780511611957.001
  396. MPP (2011), Second Amendment to License Agreement, 14.11.11. Google Scholar öffnen
  397. MPP (2013), Licences in the Pool, Geneva: Medicines Patent Pool. Google Scholar öffnen
  398. MS (2008), Pesquisa em saúde no Brasil, Revista de Saúde Pública, 42(4), 773-775. Google Scholar öffnen
  399. MS (2010), Targets and Commitments made by Member-States at the United Nations General Assembly Special Session on HIV/AIDS, Brazilian Response 2008-2009 Country Progress Report, Brasília: Brazilian Ministry of Health, Health Surveillance Secretariat, STD, AIDS and Viral Hepatitis Department, März. Google Scholar öffnen
  400. MS (2012), Estratégia para Incentivo da Produção de Fármacos no Brasil, 6º Encontro Nacional de Inovação em Fármacos e Medicamentos, Brasília. Google Scholar öffnen
  401. MS (2013a), Parcerias de Desenvolvimento Produtivo, Coordenação-Geral de Base Química e Biotecnológica Departamento do Complexo Indústrial e Inovação em Saúde, Brasília: Ministerio da Saúde, <http://portal.saude.gov.br/portal/ Google Scholar öffnen
  402. arquivos/pdf/PDP_Plano_de_desenvolvimento.pdf>. Google Scholar öffnen
  403. MS (2013b), Relação Nacional de Medicamentos Essenciais Brasília, 08.08.13, <http://portal.saude.gov.br/portal/arquivos/pdf/rename_anexos_versao_08_08_2013.pdf>. Google Scholar öffnen
  404. MSCI ESG Research (2012), Methodology Report 2012: Stakeholder Review, Haarlem: Access to Medicine Foundation, May 2012, <http://www.accesstomedicine Google Scholar öffnen
  405. index.org/sites/www.accesstomedicineindex.org/files/2012_Methodology_Report_-_Stakeholder_Review_-_May_2012.pdf>. Google Scholar öffnen
  406. MSF (2011), India Rejects Patents for Two Key AIDS Drugs, Geneva, 07.01.11, <http://www.msfaccess.org/about-us/media-room/press-releases/india-re Google Scholar öffnen
  407. jects-patents-two-key-aids-drugs>. Google Scholar öffnen
  408. MST (2013), Science, Technology and Innovation Policy 2013, New Delhi: Government of India: Ministry of Science and Technology. Google Scholar öffnen
  409. Mugabe, John O. (2005), Health Innovation Systems in Developing Countries: Strategies for Building Scientific and Technological Capacities, Background Paper Prepared for the Commission on Intellectual Property, Innovation and Public Health, Geneva: World Health Organization,. Google Scholar öffnen
  410. NACO (2013), Annual Report 2012-13, National AIDS Control Organisation Department of AIDS Control, Government of India, Ministry of Health & Family Welfare, New Delhi. Google Scholar öffnen
  411. Nair, Gopakumar G. (2008a), Impact of TRIPS on Indian Pharmaceutical Industry, Journal of Intellectual Property Rights, 13, 432-441. Google Scholar öffnen
  412. Nair, MD (2008b), Compromizing TRIPS: Brazil's Approach to Tackle the HIV/AIDS Imbroglio, Journal of Intellectual Property Rights, 13, 456-463. Google Scholar öffnen
  413. Nassif, André (2007), National Innovation System and Macroeconomic Policies: Brazil and India in Comparative Perspective, Discussion Papers, No. 184, Geneva: United Nations Conference on Trade and Development. Google Scholar öffnen
  414. Neeraj, Shekhar Sumeet (2011a), Indian Pharmaceuticals Industry: A comprehensive review report, Visakhapatnam, 05. Mai, <http://de.scribd.com/doc/54681742/Best-Pharma-Industry-Report-2011-India>. Google Scholar öffnen
  415. Neeraj, Sumeet Shekhar (2011b), India Pharmaceutical-Industry as an Export Sector, Visakhapatnam, 17. Januar, <http://www.scribd.com/doc/48571412/ Google Scholar öffnen
  416. Indian-Pharmaceutical-Export-Industry>. Google Scholar öffnen
  417. Neeraj, Sumeet Shekhar (2011c), Indian Pharmaceuticals Export Industry: Contemporary scenario, critical analysis & future trends, Visakhapatnam, 05. Oktober, <http://de.scribd.com/doc/68899825/Latest-Best-Rated-Pharma-Industry-Re Google Scholar öffnen
  418. port-India-2011-2012>. Google Scholar öffnen
  419. Nelson, Richard R. (1993), National Innovation Systems: A Comparative Analysis, New York: Oxford University Press. Google Scholar öffnen
  420. Nelson, Richard R. & Sidney G. Winter (1982), An Evolutionary Theory of Economic Change, Cambridge: Harvard University Press. Google Scholar öffnen
  421. Niosi, Jorge (2002), National systems of innovations are «x-efficient” (and x-effective): Why some are slow learners, Research Policy, 31(2), 291-302. Google Scholar öffnen doi.org/10.1016/S0048-7333(01)00142-1
  422. Niosi, Jorge (2011), Building innovation systems: an introduction to the special section, Industrial and Corporate Change, 20(6), 1637-1643. Google Scholar öffnen doi.org/10.1093/icc/dtr064
  423. Niosi, Jorge & Bertrand Bellon (1994), The global interdependence of national innovation systems: Evidence, limits, and implications, Technology in Society, 16(2), 173-197. Google Scholar öffnen doi.org/10.1016/0160-791X(94)90028-0
  424. Niosi, Jorge et al. (1993), National Systems of Innovation: In Search of a Workable Concept, Technology in Society, 15(2), 207-227. Google Scholar öffnen doi.org/10.1016/0160-791X(93)90003-7
  425. Nohlen, Dieter (2004), Vergleichende Methode, in: Dieter Nohlen & Rainer-Olaf Schultze (Hrsg.), Lexikon der Politikwissenschaft, 2. Auflage, München: Beck. Google Scholar öffnen
  426. Nohlen, Dieter & Rainer-Olaf Schultze (2002), Lexikon der Politikwissenschaft, 2. Auflage, München: Beck Verlag. Google Scholar öffnen
  427. Nortec (oJ), Portfólio Mercado Exportação, <http://www.nortecquimica.com.br/ Google Scholar öffnen
  428. produtos/2/portfolio-mercado-exportacao.html>. Google Scholar öffnen
  429. Nowotny, Helga, Peter Scott & Michael Gibbons (2001), Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty, Cambridge: Polity Press. Google Scholar öffnen
  430. NRDC (2011), Annual Report 2010-11, New Delhi. Google Scholar öffnen
  431. Nugent, Rachel (2008), Chronic Diseases in Developing Countries: Health and Economic Burdens, Annals of the New York Academy of Sciences, 1136, 70-79. Google Scholar öffnen doi.org/10.1196/annals.1425.027
  432. Nunnenkamp, Peter (1998), Lateinamerika nach der verlorenen Dekade - eine Zwischenbilanz der Reformen, Kieler Diskussionsbeiträge, Kiel: Institut für Weltwirtschaft,. Google Scholar öffnen
  433. NZZ (2013), Patentschutz in Indien: Roche entschärft Politikum, Neue Zürcher Zeitung, 16.08.13. Google Scholar öffnen
  434. Obinger, Herbert (2009), Vergleichende Politikanalyse: Eine Einführung in makro-quantitative und makro-qualitative Methoden, in: Klaus Schubert & Nils C. Bandelow (Hrsg.), Lehrbuch der Politikfeldanalyse 2.0, München: Oldenbourg, 221-244. Google Scholar öffnen
  435. Octaviani, Alessandro (2010), Biotechnology in Brazil: Promoting Open Innovation, in: Lea Shaver (Hrsg.), Access to Knowledge in Brazil: New Research on Intellectual Property, Innovation and Development, London: Bloomsbury Academic, 79-102. Google Scholar öffnen
  436. Oguamanam, Chidi (2004), Localizing Intellectual Property in the Globalization Epoch: The Integration of Indigenous Knowledge, Indiana Journal of Global Legal Studies, 11(2), 135-169. Google Scholar öffnen doi.org/10.2979/GLS.2004.11.2.135
  437. Ohly, Christopher (2012), The New India Guidelines On Similar Biologics Regulatory and Market Authorization Requirements, 08.10.12, <http://spicyip.com/docs/ Google Scholar öffnen
  438. The-New-India-Biosimilar-Guidelines-(End-Notes)(Final)-10.08.12.pdf>. Google Scholar öffnen
  439.   Google Scholar öffnen
  440. Oliveira, Maria Auxiliadora et al. (2006 ), Protección de Patentes Farmacéuticas en Brasil: Quien se Beneficia?, in: Jorge A. Bermudez & Maria Auxiliadora Oliveira (Hrsg.), La Propriedad Intelectual En El Contexto Del Acuerdo De La OMC Sobre Los ADPIC: Desafíos Para La Salud Pública, Rio de Janeiro: Centro Colborado de OPS/OMS en Políticas Farmacéuticas, Escuela National de Salud Pública Sergio Arouca, Fundación Oswaldo Cruz, 175-191. Google Scholar öffnen
  441. Orsi, Fabienne et al. (2003), Intellectual Property Rights, Anti-AIDS Policy and Generic Drugs: Lessons from the Brazilian Public Health Program, in: Jean-Paul Moatti et al. (Hrsg.), Economics of AIDS and Access to HIV/AIDS Care in Developing Countries: Issues and Challenges, Paris: ANRS, Collection Sciences Sociales et Sida, 109-135. Google Scholar öffnen
  442. Ortiz, Michael (2013), Varieties of Innovation Systems: The Governance of Knowledge Transfer in Europe, Frankfurt: Campus Verlag. Google Scholar öffnen
  443. OSDDI (2009), "Open Source Drug Discovery": An Open Collaborative Drug Discovery Model for Tuberculosis, Proposal Submitted before 'WHO Expert Working Group on R&D Financing', New Delhi. Google Scholar öffnen
  444. OSEC (2010), Brazil's Pharmaceutical Industry: Opportunities for Swiss Suppliers, Zürich: Business Network Switzerland, 22. März. Google Scholar öffnen
  445. Oyelaran-Oyeyinka, Banji (2005), Systems of Innovation and Underdevelopment: An Institutional Perspective, INTECH Discussion Paper 2005-1, Maastricht: United Nations University, Institute for New Technologies. Google Scholar öffnen
  446. Oyelaran-Oyeyinka, Banji & Gehl Padmashree Sampath (2007), Learning Through Inter-organizational Interactions: Public Research Institutes in the Nigerian (Bio)pharmaceutical System of Innovation, European Journal of Development Research, 19(1), 174-193. Google Scholar öffnen doi.org/10.1080/09578810601144483
  447. PAHO & USAID (2008), Health Systems and Services Profile: Brazil, Brasília: Pan American Health Organisation, USAID. Google Scholar öffnen
  448. Paranhos, Julia & Lia Hasenclever (2011), O Relacionamento Entre Empresas Farmacêuticas e as Instituções de Ciência e Tecnologia no Brasil: Contribuições a Partir de Uma Pesquisa de Campo, Artigo em progresso a ser enviado para o XIV Congresso Latino-iberoamericano de Gestión Tecnológica, Lima, 19.-21. Oktober. Google Scholar öffnen
  449. Parker, Rachel (2006), Small Business and Entrepreneurship in the Knowledge Economy: A Comparison of Australia and Sweden, New Political Economy, 11(2), 201-226. Google Scholar öffnen doi.org/10.1080/13563460600655573
  450. Parto, Saeed, Tommaso Ciarli & Saurabh Arora (2006), Economic Growth, innovation systems and institutional change, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Google Scholar öffnen
  451. Patel, Parimal & Keith Pavitt (1994), Uneven (and Divergent) Technological Accumulation among Advanced Countries: Evidence and a Framework of Explanation, Industrial and Corporate Change, 3(3), 759-787. Google Scholar öffnen doi.org/10.1093/icc/3.3.759
  452. Pavitt, Keith (1984), Sectoral patterns of technical change: Towards a taxonomy and a theory, Research Policy, 13, 343-373. Google Scholar öffnen doi.org/10.1016/0048-7333(84)90018-0
  453. Pedersen, Jorge Dige (2008), Globalization, Development and the State. The Performance of India and Brazil since 1990, Basingstoke: Palgrave Macmillan. Google Scholar öffnen doi.org/10.1057/9780230227354
  454. Pefile, Sibongile (2005), Developing Innovative Capacity in South Africa to Meet Health Needs, in: Ingrid Hering (Hrsg.), Innovation in Developing Countries to Meet Health Needs: Experiences of China, Brazil, South Africa and India, Oxford: The Centre for Management of IP in Health R&D, 7-36. Google Scholar öffnen
  455. Penchansky, Roy & J. William Thomas (1981), The Concept of Access: Definition and Relationship to Consumer Satisfaction, Medical Care, 19(2), 127-140. Google Scholar öffnen doi.org/10.1097/00005650-198102000-00001
  456. Perez, Carlota (1985), Microelectronics, Long Waves and World Structural Change: New Perspectives for Developing Countries, World Development, 13(3), 441-463. Google Scholar öffnen doi.org/10.1016/0305-750X(85)90140-8
  457. Perez, Carlota (2001), Technological Change and Opportunities for Development as a Moving Target, CEPAL Review, 75, 109-130. Google Scholar öffnen
  458. Perez, Carlota & Luc Soete (1988), Catching up in technology: entry barriers and windows of opportunity, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 458-479. Google Scholar öffnen
  459. Peterson, M. J. (2010), Case Study: Access to HIV Treatments in Developing Countries - Appendix E: Understanding Drug Patents, in: International Dimensions of Ethics Education in Science and Engineering, Amherst: University of Massachusetts. Google Scholar öffnen
  460. Pharmabiz.com (2012a), India, China most preferred CRAMS destinations, 10.05.12, <http://pharmabiz.com/PrintArticle.aspx?aid=68944&sid=0>. Google Scholar öffnen
  461. Pharmabiz.com (2012b), Indian pharma companies obtains 144 ANDA approvals from US FDA in 2011, 02.01.12, <http://pharmabiz.com/NewsDetails. aspx?aid=66831 Google Scholar öffnen
  462. &sid=2>. Google Scholar öffnen
  463. Pharmalot (2008), Brazil Rejects Gilead Patent On HIV Drug, 09.03.08. Google Scholar öffnen
  464. PharmaTimes (2008), Brazil rejects Gilead patent for HIV/AIDS drug Viread, 04.09.08. Google Scholar öffnen
  465. PharmExec (2013), Drug Patents Under Fire in Brazil, PharmExecBlog, 04.06.13. Google Scholar öffnen
  466. Philip, Kavita (2008), Producing Transnational Knowledge, Neoliberal Identities, and Technoscientific Practice in India, in: Beatriz da Costa & Kavita Philip (Hrsg.), Tactical Biopolitics: Art, Activism, and Technoscience, Cambridge: The MIT Press, 243-267. Google Scholar öffnen doi.org/10.7551/mitpress/9780262042499.003.0015
  467. Pietrobelli, Carlo & Roberta Rabellotti (2006), Clusters and Value Chains in Latin America: In Search of an Integrated Approach, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 1-40. Google Scholar öffnen
  468. Pietrobelli, Carlo & Roberta Rabellotti (2009), The Global Dimension of Innovation Systems: Linking Innovation Systems and Global Value Chains, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 214-238. Google Scholar öffnen
  469.   Google Scholar öffnen
  470. Pietrobelli, Carlo & Roberta Rabellotti (2011), Global Value Chains Meet Innovation Systems: Are There Learning Opportunities for Developing Countries?, World Development, 39(7), 1261-1269. Google Scholar öffnen doi.org/10.1016/j.worlddev.2010.05.013
  471. PIJIP (2008), Timeline on Brazil's Cumpulsory Licensing, Program on Information Justice and Intellectual Property, Washington, D.C.: American University Washington College of Law. Google Scholar öffnen
  472. Porter, Michael E. (1990), The Competitive Advantage of Nations, London: Macmillan. Google Scholar öffnen doi.org/10.1007/978-1-349-11336-1
  473. Poth, Robert (1998), Faire WTO?, April 1998, <http://www.rpoth.at/pastwork/ Google Scholar öffnen
  474. WTODISP1.shtml>. Google Scholar öffnen
  475. Póvoa, Luciano Martins Costa, Roberto Mazzoleni & Thiago Caliari (2011), Innovation in the Brazilian Pharmaceutical Industry post-TRIPS, 9th GLOBELICS International Conference: Creativity, Innovation and Economic Development, Buenos Aires, 15.-17. November. Google Scholar öffnen
  476. Powell, Walter W. (1990), Neither Market Nor Hierarchy: Network Forms of Organization, Research in Organizational Behavior, 12, 295-336. Google Scholar öffnen
  477. Pradhan, Jaya Prakash (2008), Indian Direct Investment in Developing Countries: Emerging Trends and Development Impacts, MPRA Papers, No. 12323, Munich: University Library of Munich. Google Scholar öffnen doi.org/10.2139/ssrn.1515654
  478. Przeworski, Adam & Henry Teune (1970), The Logic of Comparative Social Inquiry, New York: Wiley. Google Scholar öffnen
  479. Public Citizen (2013), The Non-Discriminatory Nature of India’s National Pharmaceutical Pricing Policy: Clarification in Response to the Testimony of Ms. Linda Dempsey, House Energy and Commerce Committee Hearing on India’s Industrial Policy, Washington, D.C.: Public Citizen, <http://www.citizen.org/documents/India Google Scholar öffnen
  480. %20hearing%20rebuttal%20FINAL.pdf>. Google Scholar öffnen
  481. Ragin, Charles C. (1989), The Comparative Method: Moving Beyond Qualitative and Quantitative Strategies, Berkeley: University of California Press. Google Scholar öffnen
  482. Rai, Rajnish Kumar (2009), Effect of the TRIPS-Mandated Intellectual Property Rights on Foreign Direct Investment in Developing Countries: A Case Study of the Indian Pharmaceutical Industry, The Journal of World Intellectual Property, 11(5/6), 404-431. Google Scholar öffnen
  483. Raikes, Philip, Michael Friis Jensen & Stefano Ponte (2000), Global commodity chain analysis and the French filière approach: comparison and critique, Economy and Society, 29(3), 390-417. Google Scholar öffnen doi.org/10.1080/03085140050084589
  484. Rajan, Ramkishen S. (2009), Monetary, Investment and Trade Issues in India, New York: Oxford University Press. Google Scholar öffnen doi.org/10.1142/9789814273145
  485. Ramani, Shyama V. (2002), Who is interested in biotech? R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms, Research Policy, 31(3), 381-398. Google Scholar öffnen doi.org/10.1016/S0048-7333(01)00115-9
  486. Ranbaxy Laboratories Limited (2002), Ranbaxy and Schwarz Pharma Sign a Deal to Develop New Drug to Treat Benign Prostate Hyperplasia, 27.06.02, Google Scholar öffnen
  487. <http://www.ranbaxy.com/ranbaxy-and-schwarz-pharma-sign-a-deal-to-devel Google Scholar öffnen
  488. op-new-drug-to-treat-benign-prostate-hyperplasia/>. Google Scholar öffnen
  489. Ranbaxy Laboratories Limited (2008), Annual Report, Haryana, <http://www.ran baxy.com/wp-content/uploads/2012/ranbaxy_ar2008_3deluxe.pdf>. Google Scholar öffnen
  490. Randeria, Shalini (2007), The State of Globalization: Legal Plurality, Overlapping Sovereignties and Ambiguous Alliances between Civil Society and the Cunning State in India, Theory, Culture & Society, 24(1), 1-33. Google Scholar öffnen doi.org/10.1177/0263276407071559
  491. Rao, J. Manohar (2006), Globalization, Technology and Competition: Indian Pharmaceutical Industry in the Context of the WTO, Hyderabad: Media House Publications. Google Scholar öffnen
  492. Rau, B. S. & P. V. Appaji (2012), Dynamics of Drug Master Filings at United States Food and Drug Administration, The Pharma Review,(May-June), 65-71. Google Scholar öffnen
  493. Ravenhill, John (2014), Global value chains and development, Review of International Political Economy, 21(1), 264-274. Google Scholar öffnen doi.org/10.1080/09692290.2013.858366
  494. Reddy, Madhuri et al. (2007), Oral Drug Therapy for Multiple Neglected Tropical Diseases: A Systematic Review, JAMA - The Journal of the American Medical Association, 298(16), 1911-1924. Google Scholar öffnen doi.org/10.1001/jama.298.16.1911
  495. Reh, Werner (1995), Quellen- und Dokumentenanalyse in der Politikfeldforschung: Wer steuert die Verkehrspolitik?, in: Ulrich von Alemann et al. (Hrsg.), Politikwissenschaftliche Methoden: Grundriß für Studium und Forschung, Opladen: Westdeutscher Verlag, 201-260. Google Scholar öffnen
  496. Reichman, Jerome H. (2002), From Free Riders to Fair Followers: Global Competition under the TRIPS Agreement, in: Ruth Towse & Rudi Holzhauer (Hrsg.), The Economics of Intellectual Property. Competition and International Trade, IV, Cheltenham: Edward Elgar, 446-527. Google Scholar öffnen
  497. Reis, Carla, João Pieroni Pieroni & José Oswaldo Barros de Souza (2010), Biotecnologia para saúde no Brasil, BNDES Setorial, 32, 193-230. Google Scholar öffnen
  498. Reis, Renata, Marcela Foçaça Vieira & Gabriela Costa Chaves (2009), Access to medicines and intellectual property in Brazil: A civil society perspective, in: Renata Reis et al. (Hrsg.), Intellectual Property Right and Access to ARV Medicines - Civil Society Resistance in the Global South, Rio de Janeiro: ABIA, 12-54. Google Scholar öffnen
  499. Reuters (2012), Novartis argues for Glivec patent at India's top court, 11.09.12. Google Scholar öffnen
  500. Rezaie, Rahim (2011), Health Technology Innovation by Indigenous Enterprises in China, India and Brazil, A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy, Toronto: University of Toronto, Institute of Medial Science. Google Scholar öffnen
  501. Rezaie, Rahim et al. (2008), Brazilian health biotech - fostering crosstalk between public and private sectors, Nature Biotechnology, 26(6), 627 - 644. Google Scholar öffnen doi.org/10.1038/nbt0608-627
  502. Richards, Caroline (2011), BRIC: Pricing, Reimbursement, and Regulatory Update, London: Datamonitor. Google Scholar öffnen
  503. Risse, Thomas & Ursula Lehmkuhl (2007), Regieren ohne Staat? Governance in Räumen begrenzter Staatlichkeit, Baden-Baden: Nomos. Google Scholar öffnen doi.org/10.5771/9783845206554-11
  504. Rodrik, Dani (1997), Has Globalization Gone Too Far?, Washington, D.C.: Institute for International Economics. Google Scholar öffnen doi.org/10.2307/41165897
  505. Roemer-Mahler, Anne (2013), Business conflict and global politics: The pharmaceutical industry and the global protection of intellectual property rights, Review of International Political Economy, 20(1), 121-152. Google Scholar öffnen doi.org/10.1080/09692290.2011.645848
  506. Rogers, Everett M. (2003), Diffusion of Innovations, New York: Free Press. Google Scholar öffnen
  507. Romer, Paul Michael (1994), The Origins of Endogenous Growth, Journal of Economic Perspectives, 8(1), 3-22. Google Scholar öffnen doi.org/10.1257/jep.8.1.3
  508. Rostow, Walt Whitman (1960), The Stages of Economic Growth: A Non-Communist Manifesto, Cambridge: Cambridge University Press. Google Scholar öffnen
  509. Ryan, Michael P. (2010), Patent Incentives, Technology Markets, and Public–Private Bio-Medical Innovation Networks in Brazil, World Development, 38(8), 1082-1093. Google Scholar öffnen doi.org/10.1016/j.worlddev.2009.12.013
  510. Saha, Raghav (2012), National Study on Intellectual Property and Small and Medium Sized Enterprises: India, Geneva: World Intellectual Property Organization, September. Google Scholar öffnen
  511. Salama, Bruno & Daniel Benoliel (2010), Pharmaceutical Patent Bargains: The Brazilian Experience, Cardozo Journal of International and Comparative Law 18, 633-682. Google Scholar öffnen doi.org/10.2139/ssrn.1670288
  512. Sampath, Padmashree Gehl (2010), Economic Aspects of Access to Medicines after 2005: Product Patent Protection and Emerging Firm Strategies in the Indian Pharmaceutical Industry, Maastricht: United Nations University, Institute for New Technologies. Google Scholar öffnen
  513. San Francisco Bay Guardian (2005), Balm of Gilead: Local activists back Brazil's demand that US companies allow the creation of cheap, generic AIDS drugs, 05.07.05. Google Scholar öffnen
  514. Saraswathy, Beena (2006), Mergers and Acquisitions in the Indian Pharmaceutical Industry: Nature, Structure and Performance, MPRA Papers, No. 8144, Munich: University Library of Munich. Google Scholar öffnen
  515. Sartori, Giovanni (1991), Comparing and Miscomparing, Journal of Theoretical Politics, 3(3), 243-257. Google Scholar öffnen doi.org/10.1177/0951692891003003001
  516. Sartori, Laura (2009), Consumption in Developing Nations, in: Salustiano del Campo (Hrsg.), Encyclopedia of Life Support Systems, VII, Oxford: EOLSS. Google Scholar öffnen
  517. Saúde Web (2012), Padilha assina 20 parcerias para produção de medicamentos e vacinas, <http://saudeweb.com.br/33473/padilha-assina-20-parcerias-para- Google Scholar öffnen
  518. producao-de-medicamentos-e-vacinas/>. Google Scholar öffnen
  519. Scerri, Mario & Helena Lastres (2010), Comparative Report on the State and the National System of Innovation in BRICS, BRICS Project, Rio de Janeiro. Google Scholar öffnen
  520. Scerri, Mario & Helena M. M. Lastres (Hrsg.) (2013a), The Role of the State, New Delhi: Routledge. Google Scholar öffnen
  521. Scerri, Mario & Helena M. M. Lastres (2013b), The State and the Architecture of National Systems of Innovation, in: Mario Scerri & Helena M. M. Lastres (Hrsg.), The Role of the State, New Delhi: Routledge, 1-22. Google Scholar öffnen
  522. Scharpf, Fritz W. (1997), Games Real Actors Play: Actor-Centered Institutionalism in Policy Research, Boulder: Westview Press. Google Scholar öffnen
  523. Scharpf, Fritz W. (2000), Interaktionsformen: Akteurzentrierter Institutionalismus in der Politikforschung, Wiesbaden: VS Verlag für Sozialwissenschaften. Google Scholar öffnen
  524. Schneider, Volker & Frank Janning (2006), Politikfeldanalyse: Akteure, Diskurse und Netzwerke in der öffentlichen Politik, Wiesbaden: VS Verlag für Sozialwissenschaften. Google Scholar öffnen
  525. Schöne, Helmar (2005), Die teilnehmende Beobachtung als Datenerhebungsmethode in der Politikwissenschaft: Methodologische Reflexion und Werkstattbericht, Historical Social Research, 30(1), 168-199. Google Scholar öffnen
  526. Schumacher, Christian (2012), CRAMS outsourcing in pharmaceutical and chemical research and manufacturing, part III, Science and Technology Blog, 03.09.12, <http://blog.stepchange-innovations.com/2012/09/crams-outsourc Google Scholar öffnen
  527. ing-in-pharmaceutical-and-chemical-research-and-manufactu Google Scholar öffnen
  528. ring-part-iii/#.UhONQ23TLW5>. Google Scholar öffnen
  529. Schumpeter, Joseph (1934), The Theory of Economic Development: An Inquiry Into Profits, Capital, Credit, Interest, and the Business Cycle, Port Washington: Kennikat. Google Scholar öffnen
  530. Seitz, Konrad (2000), Die neue Welt der Geo-Ökonomie: Das globale Ringen um die technologische Vorherrschaft, in: Karl Kaiser & Hans-Peter Schwarz (Hrsg.), Weltpolitik im neuen Jahrhundert, Baden-Baden: Nomos, 307-326. Google Scholar öffnen
  531. Sell, Susan (1995), Intellectual Property Protection and Antitrust in the Developing World, International Organization, 49(2), 315-349. Google Scholar öffnen doi.org/10.1017/S0020818300028411
  532. Sell, Susan (2006), Intellectual Property and the Doha Development Agenda, Global Social Policy, 6(2), 147-150. Google Scholar öffnen doi.org/10.1177/146801810600600207
  533. Sennes, Ricardo Ubiraci, Gabriel Kohlmann & Anselmo Takaki (2011), Os movimentos das multinacionais e a internacionalização da pesquisa, desenvolvimento e inovação, in: Ricardo Ubiraci Sennes & Antonio Britto Filho (Hrsg.), Inovações tecnológicas no Brasil, São Paulo: Cultura Acadêmica, 127-146. Google Scholar öffnen
  534. Serra, Narcis & Joseph E. Stiglitz (Hrsg.) (2008), The Washington Consensus Reconsidered: Towards a New Global Governance, Oxford: Oxford University Press. Google Scholar öffnen doi.org/10.1093/acprof:oso/9780199534081.003.0001
  535. Shadlen, Kenneth C. (2007), The Political Economy of AIDS Treatment: Intellectual Property and the Transformation of Generic Supply, International Studies Quarterly, 51(3), 559-581. Google Scholar öffnen doi.org/10.1111/j.1468-2478.2007.00464.x
  536. Shadlen, Kenneth C. (2008), Revolution, Reform, and Reinforcement: Latin American Responses to the Globalization of Intellectual Property, ECPR Joint Sessions Workshop No. 14: "The Politics of Intellectual Property", Rennes, 11.-16. April. Google Scholar öffnen
  537. Shadlen, Kenneth C. (2009a), The Political Contradictions of Incremental Innovation in Late Development: Lessons from Pharmaceutical Patent Examination in Brazil, American Political Science Association, 2009 Annual Meeting and Exhibition, Toronto, 03.-06. September. Google Scholar öffnen
  538. Shadlen, Kenneth C. (2009b), Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies, Comparative Politics, 42(1), 41-58. Google Scholar öffnen
  539. Shadlen, Kenneth C. (2013), The Patent Policy Trilemma, Journal für Entwicklungspolitik, 29(2), 87-104. Google Scholar öffnen doi.org/10.20446/JEP-2414-3197-29-2-87
  540. Shadlen, Kenneth C. (2011), The Political Contradictions of Incremental Innovation: Lessons from Pharmaceutical Patent Examination in Brazil, Politics & Society 39(2), 143-174. Google Scholar öffnen doi.org/10.1177/0032329211402601
  541. Shankland, Ben (2008), Novartis Seeks to Form Partnerships with Health Providers in Brazil, Global Insight, 04.04.08. Google Scholar öffnen
  542. Sharif, Naubahar (2006), Emergence and development of the National Innovation Systems concept, Research Policy, 35(5), 745-766. Google Scholar öffnen doi.org/10.1016/j.respol.2006.04.001
  543. Shaver, Lea (2010), Access to Knowledge in Brazil: New Research on Intellectual Property, Innovation and Development, Hofstra University School of Law Legal Studies Research Paper Series Research Paper 10-49 Google Scholar öffnen doi.org/10.5040/9781849660785
  544. Shiva, Vandana (2001), Protect or Plunder? Understanding Intellectual Property Rights, London: Zed Books. Google Scholar öffnen
  545. Singh, Malvinder Mohan (2006), Will India Become the Global Centre for Pharmaceutical Research & Development?, Journal of Generic Medicines, 3(3), 194-200. Google Scholar öffnen doi.org/10.1057/palgrave.jgm.4940119
  546. Sivaraman, R. (2012), Bayer plea against Natco on cancer drug dismissed, The Hindu, 16.09.12. Google Scholar öffnen
  547. Skocpol, Theda & Margaret Somers (1980), The Uses of Comparative History in Macrosocial Inquiry, Comparative Studies in Society and History, 22(2), 174-197. Google Scholar öffnen doi.org/10.1017/S0010417500009282
  548. Sleeboom, Margaret (2003), Monitored Freedom: Party and Research Reforms at CASS, China Report, 39(2), 213-227. Google Scholar öffnen doi.org/10.1177/000944550303900203
  549. Solingen, Etel (1996), Industrial policy, technology, and international bargaining: design-ing nuclear industries in Argentina and Brazil, Stanford: Stanford University Press. Google Scholar öffnen
  550. Spicy IP (2008), Roche vs NATCO: India's First "Doha Style" Compulsory License?, 16.01.08. Google Scholar öffnen
  551. Spicy IP (2010a), Breaking News: Matrix Restrained from Infringing Roche’s Cancer Patent, 19.09.10. Google Scholar öffnen
  552. Spicy IP (2010b), DIPP Discussion Paper on Compulsory Licensing in the Indian Pharmaceutical Sector: An 'Acquired' Afterthought?, 25.08.10. Google Scholar öffnen
  553. Spicy IP (2010c), DIPP receives diverse replies to its CL discussion paper, 08.10.10. Google Scholar öffnen
  554. Spicy IP (2010d), Guest Post: Requiem for a Dream?, 30.08.10. Google Scholar öffnen
  555. Spicy IP (2010e), Indian "Bayh Dole" and a Painful End to the Pursuit of Pleasure, 10.08.10. Google Scholar öffnen
  556. Spicy IP (2010f), Indian IP Policy Formulation: From Confusion to Coherence, 22.03.10. Google Scholar öffnen
  557. Spicy IP (2010g), An overview of the 'Health Impact Fund' model for accessible medicines, 06.07.10. Google Scholar öffnen
  558. Spicy IP (2010h), Roche-Natco update: "Public interest" again?, 17.05.10. Google Scholar öffnen
  559. Spicy IP (2010i), Roche-Natco update: Natco commences arguments, 28.06.10. Google Scholar öffnen
  560. Spicy IP (2010j), Roche-Natco update: Roche concludes arguments, 30.05.10. Google Scholar öffnen
  561. Spicy IP (2011a), CIPLA files for a compulsory license against Merck's Isentress, 06.04.11. Google Scholar öffnen
  562. Spicy IP (2011b), Debating the legality and the efficacy of the CSIR-Patent Office agreement to out-source prior art searches, 18.12.11. Google Scholar öffnen
  563. Spicy IP (2011c), Natco seeks license from Pfizer to manufacture a low-cost version of HIV drug, 06.01.11. Google Scholar öffnen
  564. Spicy IP (2011d), A Small Step for Natco, a Giant Leap for Generic Drugs: India’s first Compulsory Licensing Application Filed, 05.08.11. Google Scholar öffnen
  565. Spicy IP (2012a), Breaking news: Cipla succeeds in revoking Pfizer / Sugen's patent on Sunitinib, 03.10.12. Google Scholar öffnen
  566. Spicy IP (2012b), Breaking News: India's First Compulsory License Granted!, 12.03.12. Google Scholar öffnen
  567. Spicy IP (2012c), CSIR provides misleading information; aims to hide revenues from patent licensin, 22.09.12. Google Scholar öffnen
  568. Spicy IP (2012d), CSIR pulls a fast one – does a U-Turn on disclosure of royalties earned through patent licensing, 13.09.12. Google Scholar öffnen
  569. Spicy IP (2012e), Guest Post: Pharma patent developments in 2012 - A review, 31.12.12. Google Scholar öffnen
  570. Spicy IP (2012f), National Science Day – The good and bad of Indian policy initiatives for scientific research and innovation, 27.02.12. Google Scholar öffnen
  571. Spicy IP (2012g), Part I: IPCheckups & Intellectual Ventures: What are they about?, 12.11.12. Google Scholar öffnen
  572. Spicy IP (2012h), Royalty Payment by Subsidiaries: Bane of Minority Investors?, 23.12.12. Google Scholar öffnen
  573. Spicy IP (2012i), Why is it so difficult for CSIR to be ‘transparent’?, 07.04.12. Google Scholar öffnen
  574. Spicy IP (2013a), The BDR compulsory licensing application and the BMS ‘Statements of Working’, 22.08.13. Google Scholar öffnen
  575. Spicy IP (2013b), Breaking News: Second Compulsory Licensing Application Filed, 17.03.13. Google Scholar öffnen
  576. Spicy IP (2013c), The Dasatinib compulsory license conundrum, 16.09.13. Google Scholar öffnen
  577. Spicy IP (2013d), DIPP to issue CLs for Herceptin, Dastinib & Ixabepilone – End of the line for Big Pharma’s patents in the Indian market?, 12.01.13. Google Scholar öffnen
  578. Spicy IP (2013e), The ‘Emcure model’ of Foreign Investment and Joint-Ventures, 31.01.13. Google Scholar öffnen
  579. Spicy IP (2013f), Negotiating licenses between patent holders and generic producers: the Medicines Patent Pool, 28.06.13. Google Scholar öffnen
  580. Spicy IP (2013g), Patent Ambush: Big Pharma vs Generics, 25.01.13. Google Scholar öffnen
  581. Spicy IP (2013h), Patent war intensifies: Glenmark launches generic version of Merck’s Januvia, 02.04.13. Google Scholar öffnen
  582. Spicy IP (2013i), The Royalty Payment Siphon by MNCs - Independent Director and Minority Voting as Possible Solutions?, 09.01.13. Google Scholar öffnen
  583. Spicy IP (2013j), SpicyIP Events: FMC-DSIR-APTDC Workshop for Identifying the Technologies for Acquisition, 13.06.13. Google Scholar öffnen
  584. Spicy IP (2013k), Why aren’t there any takers for compulsory licenses?, 12.02.13. Google Scholar öffnen
  585. Srholec, Martin (2011), A multilevel analysis of innovation in developing countries, Industrial and Corporate Change, 20(6), 1539-1569. Google Scholar öffnen doi.org/10.1093/icc/dtr024
  586. Srinivasan, Sandhya (2009), The Clinical Trials Scenario in India, Economic & Political Weekly, 44(35). Google Scholar öffnen doi.org/10.20529/IJME.2009.036
  587. Steffen Guise, Mônica & Adelina de Oliveira Novaes (2011), Balancing Health and Wealth: The Case of Patents and Access to Medicines in Brazil. Google Scholar öffnen
  588. Stewart, Frances (1977), Technology and Underdevelopment, London: Macmillan. Google Scholar öffnen doi.org/10.1007/978-1-349-02914-3
  589. Stewart, Frances (1984), Facilitating Indigenous Technical Change in Third World Countries, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London: Macmillan, 81-94. Google Scholar öffnen doi.org/10.1007/978-1-349-17487-4_4
  590. Sundar, Mahesh (2013), Glenmark's Unique Indian Approach to successful NCE Research, <http://www.maheshsundar.com/Home/recent-developments-views-opin Google Scholar öffnen
  591. ions-in-pharma-archives/glenmark-s-unique-indian-approach-to-success Google Scholar öffnen
  592. ful-nce-research>. Google Scholar öffnen
  593. Sweet, Cassandra M. (2007), Regulating the Tigers: The Institutional Dynamics of Indo-Brazilian Trade Reflections from the Pharmaceutical Sector, ELSNIT Conference, Institutional Dimensions of Integration and Trade, Barcelona, 01. Oktober. Google Scholar öffnen
  594. Tachinardi, Maria Helena (1993), A Guerra Das Patentes: O conflito Brasil x EUA sobre propriedade intelectual, Sao Paulo: Paz e Terra. Google Scholar öffnen
  595. TB Alliance (2013), TB Alliance Licenses Late-stage TB Program to CSIR-OSDD, 20.03.13, <http://www.tballiance.org/newscenter/view-brief.php?id=1076>. Google Scholar öffnen
  596. Thach, Sharon & Susan J. Marsnik (2009), Patent Standards under TRIPS and the Pharmaceutical Industries in Brazil and India, Latin American Business Review, 10(4), 237-261. Google Scholar öffnen doi.org/10.1080/10978520903297616
  597. The Indian Express (2011), Lupin inks pact with Brazil for TB drug supply, 05.01.11. Google Scholar öffnen
  598. The Indian Express (2013a), CCI rules out case against US-based pharmaceutical, Gilead Sciences, 12.03.13. Google Scholar öffnen
  599. The Indian Express (2013b), Govt moves to make three key cancer drugs cheaper, 12.01.13. Google Scholar öffnen
  600. The Observatory (2010), The Observatory of Economic Complexity, Massachusetts Institute of Technology, <http://atlas.media.mit.edu/>. Google Scholar öffnen
  601. ThePharmaLetter (2001), Wockhardt acquires all Rhein Biotech JV, 11.09.01. Google Scholar öffnen
  602. ThePharmaLetter (2005), Wockhardt sets up JVs in Latin America and South Africa, 21.02.05. Google Scholar öffnen
  603. Thorelli, Hans B. (1986), Networks: Between Markets and Hierarchies, Strategic Management Journal, 7(1), 37-51. Google Scholar öffnen doi.org/10.1002/smj.4250070105
  604. Thorsteinsdóttir, Halla et al. (2004a), Conclusions: Promoting Biotechnology Innovation in Developing Countries, Nature Biotechnology, 22 (12s), DC48-DC52. Google Scholar öffnen
  605. Thorsteinsdóttir, Halla et al. (2004b), Introduction: Promoting Global Health Through Biotechnology, Nature Biotechnology, 22(12s), DC3-DC7. Google Scholar öffnen
  606. Times of India (2004), Novartis licences Torrent's AGE breaker molecule, 30.07.04. Google Scholar öffnen
  607. Times of India (2010), Govt may limit FDI in pharma sector at 49%, 06.09.10. Google Scholar öffnen
  608. Times of India (2012), PMO push for free drugs at govt hospitals, 13.02.12. Google Scholar öffnen
  609. Times of India (2013), Medicines Patent Pool and Roche tie up to increase access of key HIV drug, 05.08.13. Google Scholar öffnen
  610. Timmermans, Karin & Togi Hutadjulu (2000), Report, ASEAN Workshop on the TRIPs Agreement and its Impact on Pharmaceuticals, Jakarta, 02.-04. Mai. Google Scholar öffnen
  611. Truffer, Bernhard, Harald Rohracher & Jochen Markard (2009), The Analysis of Institutions in Technological Innovation Systems - A Conceptual Framework Applied to Biogas Development in Austria, DRUID Summer Conference 2009, Copenhagen, 16.-20. Juni. Google Scholar öffnen doi.org/10.1016/j.respol.2009.01.013
  612. Tyfield, David (2008), Enabling TRIPs: The pharma-biotech-university patent coalition, Review of International Political Economy, 15(4), 535-566. Google Scholar öffnen doi.org/10.1080/09692290802260555
  613. U.S. PIRG & Community Catalyst (2013), Top Twenty Pay-for-delay Drugs: How Drug Industry Payoffs Delay Generics, Inflate Prices and Hurt Consumers, July 2013. Google Scholar öffnen
  614. UN (2012), The Millennium Development Goals Report 2012, New York: United Nations. Google Scholar öffnen doi.org/10.18356/cd6d8dfe-en
  615. UNAIDS (2012), UNAIDS Report on the global AIDS epidemic, Geneva: Joint United Nations Programme on HIV/AIDS. Google Scholar öffnen
  616. UNESCO (2010), UNESCO Science Report 2010: The Current Status of Science around the World, Paris. Google Scholar öffnen
  617. Urias, Eduardo & João Furtado (2009), Institutional changes and their impacts on the Brazilian Pharmaceutical Industry: Is there an Innovation System on the way?, 7th GLOBELICS International Conference: Inclusive Growth, Innovation and Technological Change: education, social capital and sustainable development, Dakar, 06.-08. Oktober. Google Scholar öffnen
  618. Van Dyck, Pooja (2007), Importing Western Style, Exporting Tragedy: Changes in Indian Patent Law and Their Impact on AIDS Treatment in Africa, North Western Journal of Technology and Intellectual Property, 6(1), 138-151. Google Scholar öffnen
  619. Veembur, Arun (2004), CRO: Boom Time for India, Siliconindia,(June), 50-52. Google Scholar öffnen
  620. Veloso, Francisco & Jorge Mario Soto (2001), Incentives, Infrastructure and Institutions: Perspectives on Industrialization and Technical Change in Late-Developing Nations, Technological Forecasting and Social Change, 66, 87-109. Google Scholar öffnen doi.org/10.1016/S0040-1625(99)00065-7
  621. Vieira, Fabiola Sulpino (2009), Ministry of Health's depending on drugs: program trends from 2002-2007, Revista de Saúde Pública, 43(4), 206-209. Google Scholar öffnen doi.org/10.1590/S0034-89102009005000041
  622. Viotti, Eduardo B. (2002), National Learning Systems - A new approach on technological change in late industrializing economies and evidences from the cases of Brazil and South Korea, Technological Forecasting & Social Change, 69, 653-680. Google Scholar öffnen doi.org/10.1016/S0040-1625(01)00167-6
  623. von Alemann, Ulrich & Wolfgang Tönnesmann (1995), Grundriß: Methoden in der Politikwissenschaft, in: Ulrich von Alemann (Hrsg.), Politikwissenschaftliche Methoden: Grundriss für Studium und Forschung, Opladen: Westdeutscher Verlag, 17-140. Google Scholar öffnen
  624. Wade, Robert (2003), What strategies are viable for developing countries today? The World Trade Organization and the shrinking of ‘development space’, Review of International Political Economy, 10(4), 621-644. Google Scholar öffnen doi.org/10.1080/09692290310001601902
  625. Walgenbach, Peter & Renate Meyer (2008), Neoinstitutionalistische Organisationstheorie, Suttgart: Kohlhammer. Google Scholar öffnen
  626. Waning, Brenda, Ellen Diedrichsen & Suerie Moon (2010), A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries, Journal of the International AIDS Society, 13(35). Google Scholar öffnen doi.org/10.1186/1758-2652-13-35
  627. Westphal, Larry E., W. Rhee Yung & Garry Pursell (1984), Sources of Technological Capability in South Korea, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London & Basingstoke: Macmillan, 279-300. Google Scholar öffnen doi.org/10.1007/978-1-349-17487-4_15
  628. Wharton (2012), Sparring Over Sorafenib: How Will Natco’s Move against Bayer Affect Pharma Licensing?, Philadelphia: Knowledge@Wharton, The Wharton School, University of Pennsylvania, 19.04.12. Google Scholar öffnen
  629. Whitley, Richard (2000), Divergent Capitalisms: The Social Structuring and Change of Business Systems, Oxford: Oxford University Press. Google Scholar öffnen
  630. WHO (2002), The Selection of Essential Medicines, WHO Policy Perspectives on Medicines, No. 4, Juni. Google Scholar öffnen doi.org/10.1080/13603120110073237
  631. WHO (2003), New initiative to research and develop drugs for the world’s most neglected diseases, Delhi: World Health Organization, 25.06.03, <http://www. Google Scholar öffnen
  632. who.int/mediacentre/news/releases/2003/pr51/en/#>. Google Scholar öffnen
  633. WHO (2004a), Equitable access to essential medicines: a framework for collective action, WHO Policy Perspectives on Medicines, No. 8, Juni. Google Scholar öffnen
  634. WHO (2004b), The World Medicines Situation, Geneva. Google Scholar öffnen
  635. WHO (2011), Noncommunicable diseases, Fact sheet, Geneva, March 2013, <http://www.who.int/mediacentre/factsheets/fs355/en/#>. Google Scholar öffnen
  636. WHO (2012), Defining Disease Types I, II AND III, Background document provided by the WHO Secretariat, Geneva: WHO Secretariat. Google Scholar öffnen
  637. WHO (2013), World Health Statistics 2013, Geneva: WHO Press. Google Scholar öffnen
  638. WHO, WIPO & WTO (2012), Promoting Access to Medical Technologies and Innovation: Intersections between public health, intellectual property and trade, Geneva: World Health Organization, World Intellectual Property Organization and World Trade Organization. Google Scholar öffnen
  639. Williamson, John (1989), What Washington Means by Policy Reform, in: John Williamson (Hrsg.), Latin American Adjustment: how much has happended?, Washington, D.C.: Institute for International Economics. Google Scholar öffnen
  640. WIPO (2011), World Intellectual Property Report: The Changing Face of Innovation, WIPO Economics & Statistics Series, Geneva: World Intellectual Property Organization. Google Scholar öffnen
  641. World Bank (2002), World Development Report 2002: Building Institutions for Markets, New York: Oxford University Press. Google Scholar öffnen
  642. World Bank (2009), World Development Report 2009: Reshaping Economic Geography, Washington, D.C.: The World Bank. Google Scholar öffnen
  643. World Bank (2010), Investing Across Borders 2010: Indicators of foreign direct investment regulation in 87 countries, Washington, D.C.: The World Bank Group. Google Scholar öffnen
  644. Wright, Alan (2008), Innovation in Brazil: Public Policies and Business Strategies, March 2008, Washington, D.C.: Woodrow Wilson Center for Scholars, Brazil Institute and the Program on Science, Technology, America and The Global Economy. Google Scholar öffnen
  645. Yeats, Alexander J. (2001), Just How Big is Global Production Sharing?, in: Sven W. Arndt & Henryk Kierzkowski (Hrsg.), Fragmentation: new production patterns in the world economy, Oxford: Oxford University Press, 108-143. Google Scholar öffnen
  646. Young, Terry A. (2010), The Rise of Intellectual Property and Incubation in India, Beyond the First World, 1(8). Google Scholar öffnen
  647. Zanatta, Mariana et al. (2008), National policies to attract FDI in R&D: An assessment of Brazil and selected countries, Research Paper, No. 69, Helsinki: United Nations University, World Institute for Development Economic Research . Google Scholar öffnen

Ähnliche Veröffentlichungen

aus dem Schwerpunkt "Globalisierung", "Regierung & Regierungslehre & Verwaltung", "Politik allgemein"
Cover des Buchs: Weltbilder und Weltordnung
Lehrbuch Kein Zugriff
Gert Krell, Peter Schlotter, Alexandra Homolar, Frank A. Stengel
Weltbilder und Weltordnung
Cover des Buchs: (Neu-)Ordnung
Sammelband Kein Zugriff
Uwe Wagschal, Marius Fröhle
(Neu-)Ordnung
Cover des Buchs: Arenen des Diskurses
Sammelband Kein Zugriff
Thomas Schölderle, Laura Martena
Arenen des Diskurses
Cover des Buchs: Europa
Monographie Kein Zugriff
Hans Jörg Schrötter
Europa
Cover des Buchs: Auf dem Weg zum »Präsidialsystem alla Turca?«
Monographie Kein Zugriff
Mahir Tokatlı
Auf dem Weg zum »Präsidialsystem alla Turca?«

Hinweis

Dieses Werk ist urheberrechtlich geschützt und darf nur nach den Vorgaben der Nutzungs- und Lizenzvereinbarung genutzt werden. Jede darüber hinaus gehende Nutzung des Werkes ist ausdrücklich untersagt und wird verfolgt.

Feedback geben

Wir freuen uns über Ihr Feedback zu Inhalten und Funktionen. Ihre Nachricht hilft uns, unseren Service stetig zu verbessern.

Bewertung
Bild anhängen
oder hier ablegen
PNG oder JPG (max. 3 MB)

Willkommen auf Inlibra – Ihrer Plattform für digitale Fachinformationen

Nomos, C.H.Beck, VDI und über 100 weitere Verlage bündeln hier ihre Inhalte zu einer der größten Plattformen für digitale Fachinformationen.

Effizient recherchieren, langfristig zitieren, verlässlich nutzen – alles vereint an einem Ort.

Anmelden

Passwort vergessen?
Login via Open Athens
Noch kein Benutzerkonto?
Jetzt registrieren

Publikation zitieren

Download: RIS BibTex